ID Ca20chr3 standard; DNA; UNK; 1798341 BP. XX AC unknown; XX DE 1798341 nucleotides XX FH Key Location/Qualifiers FH FT CDS join(complement(160353..160799), FT complement(158027..160351)) FT /gene="orf19.1288" FT /Ca19Contig="Ca19-1739|complement(2..310)" FT /synonym="IPF19113.1, IPF9601.2, IPF18935.1, Contig4- FT 2784_0005, orf6.882, orf6.1167, CA0347, orf19.3070.1, FT orf19.1809" FT /remarks="Predicted 3-hydroxyacyl-CoA epimerase, required FT for fatty acid beta-oxidation; upregulated upon FT phagocytosis; transcription is regulated by Mig1p; FT expression is regulated upon white-opaque switching" FT CDS join(162953..164290,164292..165317) FT /gene="orf19.1289" FT /Ca19Contig="Ca19-1739|2464..4776" FT /synonym="IPF9596.1, IPF18377.2, Contig4-2784_0001, FT orf6.883, orf6.5315, CA0214, orf19.6154" FT /remarks="Putative glycerol-3-phosphate O-acyltransferase; FT fungal-specific (no human or murine homolog)" FT CDS complement(232945..233892) FT /gene="orf19.158" FT /Ca19Contig="Ca19-1364|1292..2218" FT /synonym="Contig4-1515_0003, orf6.136" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS join(524595..524879,524881..525207,525209..525283, FT 525283..525357,525359..526261) FT /gene="orf19.1606" FT /Ca19Contig="Ca19-10123|complement(301..1926)" FT /synonym="orf19.9174, IPF19678.2, IPF19688.1, Contig4- FT 2260_0002, orf6.1087, CA0301" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; Plc1p- FT regulated" FT CDS complement(518103..520892) FT /gene="orf19.1607" FT /Ca19Contig="Ca19-10123|5629..8418" FT /synonym="orf19.9175, IPF13562.2, IPF14418.3, Contig4- FT 2034_0002, Contig4-2034_0003, Contig4-2034_0004, Contig4- FT 2260_0010, orf6.1088, orf6.1933, CA0796" FT /remarks="Putative transporter of divalent cations; hyphal- FT induced expression; fungal-specific (no human or murine FT homolog)" FT CDS complement(515373..517139) FT /gene="orf19.1608" FT /Ca19Contig="Ca19-10123|9382..11148" FT /synonym="orf19.9176, IPF25615.1, IPF13564.2, Contig4- FT 1822_0006, orf6.1934, CA0797" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 513223..515223 FT /gene="orf19.1609" FT /Ca19Contig="Ca19-10123|complement(11298..13298)" FT /synonym="orf19.9177, IPF13565.2, IPF19865.2, Contig4- FT 1822_0002, Contig4-1822_0003, orf6.1340, orf6.1935, FT CA0798" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 511775..512908 FT /gene="orf19.1610" FT /Ca19Contig="Ca19-10123|complement(13613..14746)" FT /synonym="orf19.9178, IPF13567.2, IPF14825.1, orf6.1339, FT orf6.1936, CA0799" FT /remarks="Putative protein of unknown function, FT transcription is activated in the presence of elevated FT CO2; predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(510148..511080) FT /gene="orf19.1611" FT /Ca19Contig="Ca19-10123|15441..16373" FT /synonym="orf19.9179, IPF18870.2, IPF14827.2, orf6.1338, FT orf6.1937, CA0429" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 507578..509629 FT /gene="orf19.1613" FT /Ca19Contig="Ca19-10123|complement(16892..18943)" FT /synonym="orf19.9180, IPF12617.3, IPF14829.2, orf6.1091, FT orf6.1336, CA0428" FT /remarks="Protein described as acetolactate synthase; FT regulated by Gcn4p; induced in response to amino acid FT starvation (3-aminotriazole treatment)" FT CDS 505167..506774 FT /gene="orf19.1614" FT /Ca19Contig="Ca19-10123|complement(19747..21354)" FT /synonym="orf19.9181, IPF12620.1, IPF18990.2, Contig4- FT 2400_0002, orf6.1090, orf6.1335, CA0302" FT /remarks="Ammonium permease; Mep1p is a more efficient FT ammonium permease than Mep2p, whereas Mep2p has additional FT regulatory role; not essential for viability; 11 predicted FT transmembrane regions; low mRNA abundance; hyphal FT downregulated" FT CDS 499948..503292 FT /gene="orf19.1616" FT /Ca19Contig="Ca19-10123|complement(23229..26573)" FT /synonym="orf19.9183, IPF12262.3, IPF12624.3, Contig4- FT 2400_0003, orf6.1089, orf6.555, CA0267, orf6.1030" FT /remarks="Protein lacking an ortholog in S. cerevisiae; FT transposon mutation affects filamentous growth; FT transcriptionally repressed by A1p and Alpha2p in white- FT phase cells, a-specific and induced by alpha factor" FT CDS 497865..499037 FT /gene="orf19.1617" FT /Ca19Contig="Ca19-10123|complement(27484..28656)" FT /synonym="orf19.9184, IPF12263.2, IPF17776.2, Contig4- FT 2597_0008, orf6.1029, orf6.6455, YDR282C, CA6191" FT /remarks="Protein similar to S. cerevisiae Ydr282cp; FT transposon mutation affects filamentous growth" FT CDS complement(493847..495988) FT /gene="orf19.1618" FT /Ca19Contig="Ca19-10123|30533..32674" FT /synonym="orf19.9186, IPF17771.2, IPF12267.2, Contig4- FT 2597_0003, orf6.1027, orf6.6454, CA4016" FT /remarks="Glucosamine-6-phosphate synthase; enzyme of FT chitin/hexosamine biosynthesis; homotetrameric; inhibited FT by UDP-GlcNAc, FMDP, N-acyl peptide, kanosamine-6-P; FT functional homolog of S. cerevisiae Gfa1p; growth-phase FT regulated; catalytic Cys" FT CDS complement(489559..491319) FT /gene="orf19.1619" FT /Ca19Contig="Ca19-10123|35202..36962" FT /synonym="orf19.9187, IPF25612.1, IPF4233.2, Contig4- FT 2798_0016, orf6.6453, CA4014" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(488882..489370) FT /gene="orf19.1620" FT /Ca19Contig="Ca19-10123|37151..37639" FT /synonym="orf19.9188, IPF25665.1, IPF4234.2, Contig4- FT 2798_0014, orf6.6452, CA4013" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; FT transcription is induced in response to alpha pheromone in FT SpiderM medium" FT CDS complement(485347..486855) FT /gene="orf19.1621" FT /Ca19Contig="Ca19-10123|39666..41174" FT /synonym="orf19.9189, IPF25624.1, IPF4239.2, Contig4- FT 2798_0009, orf6.6451, CA4012" FT /remarks="G-protein alpha subunit; regulates filamentous FT growth; reports differ on a role in cAMP-mediated glucose FT signaling, cAMP-PKA pathway, MAP kinase cascade; Gpr1p C FT terminus binds Gpa2p; regulates HWP1 and ECE1" FT CDS complement(481126..484905) FT /gene="orf19.1622" FT /Ca19Contig="Ca19-10123|41616..45395" FT /synonym="orf19.9190, IPF25696.1, IPF4240.2, Contig4- FT 2798_0005, orf6.6450, orf6.788, CA4011" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 479390..480889 FT /gene="orf19.1623" FT /Ca19Contig="Ca19-10123|complement(45632..47131)" FT /synonym="orf19.9191, IPF4242.2, IPF29344.1, Contig4- FT 2798_0003, orf6.6449, orf6.787, CA0183" FT /remarks="Transcription factor, AP-1 family; role in FT oxidative stress response and resistance, multidrug FT resistance; oxidative stress regulates nuclear FT localization; partially complements S. cerevisiae yap1 FT mutation; human neutrophil-induced" FT CDS join(complement(477746..477764), FT complement(475279..477665)) FT /gene="orf19.1624" FT /Ca19Contig="Ca19-10123|join(48636..48660,48856..51242)" FT /synonym="orf19.9192, IPF17282.3, IPF4245.2, orf6.6448, FT orf6.786, CA4010" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(474353..474775) FT /gene="orf19.1625" FT /Ca19Contig="Ca19-10123|51746..52168" FT /synonym="orf19.9193, IPF25669.1, IPF4247.1, Contig4- FT 2997_0026, orf6.6447, CA4009" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; FT repressed by nitric oxide" FT CDS complement(472760..473899) FT /gene="orf19.1626" FT /Ca19Contig="Ca19-10123|52622..53761" FT /synonym="orf19.9194, IPF25636.1, IPF4248.2, Contig4- FT 2997_0025, orf6.6446, CA4008" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(470908..472461) FT /gene="orf19.1628" FT /Ca19Contig="Ca19-10123|54060..55613" FT /synonym="orf19.9196, IPF25621.1, IPF4250.1, Contig4- FT 2997_0024, orf6.6444, CA4007" FT /remarks="Protein not essential for viability; similar to FT S. cerevisiae Lap4p, which is a vacuolar aminopeptidase" FT CDS join(complement(470084..470087),complement(469887..469931), FT complement(467563..469796)) FT /gene="orf19.1630" FT /Ca19Contig="Ca19-10123|join(56434..56437,56590..56634,5672 FT 5..58958)" FT /synonym="orf19.9198, IPF25601.1, IPF4253.1, Contig4- FT 2997_0020, orf6.6442, CA4006" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(465490..466620) FT /gene="orf19.1631" FT /Ca19Contig="Ca19-10123|59901..61031" FT /synonym="orf19.9199, IPF25638.1, IPF4255.2, Contig4- FT 2997_0019, orf6.6441, CA4005" FT /remarks="Delta(24)-sterol C-methyltransferase, converts FT zymosterol to fecosterol in ergosterol biosynthesis by FT methylating position C-24; mutation confers nystatin FT resistance; fluconazole-induced; transcription increased FT in azole-resistant strain" FT CDS complement(463652..464869) FT /gene="orf19.1632" FT /Ca19Contig="Ca19-10123|61652..62869" FT /synonym="orf19.9200, IPF25634.1, IPF4256.2, Contig4- FT 2997_0018, orf6.6440, CA4004" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 461349..463580 FT /gene="orf19.1633" FT /Ca19Contig="Ca19-10123|complement(62941..65172)" FT /synonym="orf19.9201, IPF25598.1, IPF4257.2, Contig4- FT 2997_0017, orf6.6439, CA4003" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS join(459760..459775,459846..460960) FT /gene="orf19.1634" FT /Ca19Contig="Ca19-10123|complement(join(66746..66761,65561. FT .66675))" FT /synonym="orf19.9202, IPF25639.1, IPF4258.2, Contig4- FT 2997_0015, orf6.6438, CA4002" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 458252..458749 FT /gene="orf19.1635" FT /Ca19Contig="Ca19-10123|complement(67772..68269)" FT /synonym="orf19.9203, IPF25668.1, IPF4260.2, RPL15B, FT Contig4-2997_0012, orf6.6437, CA4001" FT /remarks="Predicted ribosomal protein; downregulated in FT the presence of human whole blood or polymorphonuclear FT (PMN) cells; genes encoding cytoplasmic ribosomal subunits FT are downregulated upon phagocytosis by murine macrophage; FT Tbf1p-activated" FT CDS 456542..457924 FT /gene="orf19.1636" FT /Ca19Contig="Ca19-10123|complement(68597..69979)" FT /synonym="orf19.9204, IPF25630.1, IPF4262.2, Contig4- FT 2997_0011, orf6.6436, CA4000" FT /remarks="Protein with sterile alpha motif (SAM) and Ras- FT associated domain (RAD); similar to S. cerevisiae Rad50p, FT which is involved in signal transduction via interaction FT with and regulation of MAPKKK " FT CDS complement(454480..455421) FT /gene="orf19.1637" FT /Ca19Contig="Ca19-10123|71100..72041" FT /synonym="orf19.9205, IPF25641.1, IPF10447.2, Contig4- FT 2997_0006, orf6.6435, CA3999" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 451886..454471 FT /gene="orf19.1638" FT /Ca19Contig="Ca19-10123|complement(72050..74635)" FT /synonym="orf19.9206, IPF10446.3, IPF29331.1, Contig4- FT 2997_0003, Contig4-2997_0005, orf6.625, orf6.6434, CA0137" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS join(complement(450330..451109), FT complement(449942..450328)) FT /gene="orf19.1639" FT /Ca19Contig="Ca19-10123|join(75412..76191,76193..76579)" FT /synonym="orf19.9207, IPF10444.2, IPF18268.1, IPF15933.2, FT Contig4-2347_0009, orf6.624, orf6.6432, orf6.6433, CA0136, FT CA6260, orf19.1640" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 448621..449892 FT /gene="orf19.1641" FT /Ca19Contig="Ca19-10123|complement(76629..77900)" FT /synonym="orf19.9208, IPF19209.2, IPF10443.2, Contig4- FT 2347_0008, orf6.623, orf6.6431, CA3998" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(447097..447717) FT /gene="orf19.1642" FT /Ca19Contig="Ca19-10123|78804..79424" FT /synonym="orf19.9209, IPF25650.1, IPF10442.1, Contig4- FT 2347_0006, orf6.6430, CA3997" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 446051..447034 FT /gene="orf19.1643" FT /Ca19Contig="Ca19-10123|complement(79487..80470)" FT /synonym="orf19.9211, IPF25663.1, IPF10440.2, Contig4- FT 2347_0004, orf6.2338, orf6.6429, CA3996" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 443339..445864 FT /gene="orf19.1646" FT /Ca19Contig="Ca19-10123|complement(80657..83182)" FT /synonym="orf19.9215, IPF11615.2, IPF29332.1, Contig4- FT 2368_0004, orf6.2334, CA1047" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS join(complement(442872..443105), FT complement(441998..442789)) FT /gene="orf19.1647" FT /Ca19Contig="Ca19-10123|83849..84523" FT /synonym="orf19.9216, IPF25648.1, IPF11617.2, Contig4- FT 2368_0002, orf6.2333, CA1046" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 437980..441978 FT /gene="orf19.1648" FT /Ca19Contig="Ca19-10123|complement(84543..88541)" FT /synonym="orf19.9217, IPF25689.1, IPF11620.2, orf6.2332, FT CA1045" FT /remarks="Protein described as DNA double-strand break FT repair factor; involved in response to oxidative stress FT and drug resistance" FT CDS 436614..437858 FT /gene="orf19.1649" FT /Ca19Contig="Ca19-10123|complement(88663..89907)" FT /synonym="orf19.9218, IPF11621.2, IPF15802.3, orf6.2331, FT orf6.825, CA1044" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(436213..436383) FT /gene="orf19.1650" FT /Ca19Contig="Ca19-10123|90003..90308" FT /synonym="orf19.9219, IPF15801.2, IPF19134.2, Contig4- FT 1923_0001, orf6.2330, orf6.826, CA1043" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(434168..434695) FT /gene="orf19.1651" FT /Ca19Contig="Ca19-10123|91826..92353" FT /synonym="orf19.9220, IPF25661.1, IPF15799.1, Contig4- FT 1923_0003, orf6.827, CA0196" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(429978..432107) FT /gene="orf19.1652" FT /Ca19Contig="Ca19-10123|94414..96543" FT /synonym="orf19.9221, IPF15088.2, IPF15794.2, Contig4- FT 2710_0011, Contig4-2710_0012, orf6.3137, orf6.828, CA1572" FT /remarks="Predicted acyl-CoA oxidase; farnesol regulated" FT CDS complement(428931..429521) FT /gene="orf19.1653" FT /Ca19Contig="Ca19-10123|97000..97590" FT /synonym="orf19.9222, IPF25655.1, IPF15087.2, Contig4- FT 2710_0009, orf6.3138, CA1573" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; FT possibly spurious ORF (Annotation Working Group FT prediction)" FT CDS complement(428005..428592) FT /gene="orf19.1654" FT /Ca19Contig="Ca19-10123|97929..98516" FT /synonym="orf19.9223, IPF25652.1, IPF20085.1, Contig4- FT 2710_0007, orf6.3139" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 425705..427879 FT /gene="orf19.1655" FT /Ca19Contig="Ca19-10123|complement(98642..100816)" FT /synonym="orf19.9224, IPF25599.1, IPF13474.2, POX1-1, FT Contig4-2710_0004, orf6.3140, CA1574" FT /remarks="Putative acyl-CoA oxidase; enzyme of fatty acid FT beta-oxidation; induced during macrophage infection; FT expression is opaque specific; has putative peroxisome FT targeting signal" FT CDS complement(423084..423251) FT /gene="orf19.1655.3" FT /Ca19Contig="Ca19-10123|103270..103437" FT /synonym="IPF18656.2, IPF13678.2, Contig4-1759_0003, FT CA0370" FT /remarks="ORF Predicted by Annotation Working Group" FT CDS complement(418845..420641) FT /gene="orf19.1656" FT /Ca19Contig="Ca19-10123|105880..107676" FT /synonym="orf19.9225, IPF25614.1, IPF13675.2, Contig4- FT 2722_0003, orf6.1219, CA0369" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS join(complement(416723..417015), FT complement(415128..416166)) FT /gene="orf19.1658" FT /Ca19Contig="Ca19-10123|join(109506..109798,110355..111393) FT " FT /synonym="orf19.9226, orf19.9227, IPF19685.1, IPF29349.1, FT Contig4-1784_0004, Contig4-2479_0002, Contig4-2479_0003, FT orf6.833, orf6.834, CA0198, orf19.1657" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 412987..414750 FT /gene="orf19.1659" FT /Ca19Contig="Ca19-10123|complement(111771..113534)" FT /synonym="orf19.9228, IPF25617.1, IPF12530.2, Contig4- FT 2479_0006, orf6.5734, CA3463" FT /remarks="Putative glucosyltransferase involved in cell FT wall mannan biosynthesis; transcription is elevated in FT nik1 and sln1 homozygous null mutants, but not in the chk1 FT null mutant" FT CDS complement(410701..412323) FT /gene="orf19.1661" FT /Ca19Contig="Ca19-10123|114198..115820" FT /synonym="orf19.9230, IPF25616.1, IPF12528.2, Contig4- FT 2479_0009, orf6.5736, CA3464" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 409410..410321 FT /gene="orf19.1662" FT /Ca19Contig="Ca19-10123|complement(116200..117111)" FT /synonym="orf19.9231, IPF25644.1, IPF12526.2, Contig4- FT 2479_0010, orf6.5737, CA3466" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(405692..407077) FT /gene="orf19.1663" FT /Ca19Contig="Ca19-10123|119444..120829" FT /synonym="orf19.9232, IPF25631.1, IPF6319.2, Contig4- FT 3069_0003, orf6.5738, CA3467" FT /remarks="Alpha-1,2-mannosyl transferase; adds third FT mannose during cell-wall mannoprotein biosynthesis; FT partially redundant with Mnt1p; role in adherence and FT virulence; expressed in yeast-form and hyphal cells; FT fungal-specific" FT CDS 402926..405526 FT /gene="orf19.1664" FT /Ca19Contig="Ca19-10123|complement(120995..123595)" FT /synonym="orf19.9233, IPF25593.1, IPF6318.2, Contig4- FT 3069_0005, orf6.5739, CA3468" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; FT decreased expression observed in an ssr1 homozygous null FT mutant" FT CDS complement(399499..400794) FT /gene="orf19.1665" FT /Ca19Contig="Ca19-10123|125727..127022" FT /synonym="orf19.9234, IPF25633.1, IPF6315.2, Contig4- FT 3069_0008, Contig4-3069_0009, orf6.5740, CA3469" FT /remarks="Alpha-1,2-mannosyl transferase; adds second FT mannose during cell-wall mannoprotein biosynthesis; FT required for wild-type virulence and adherence to FT epithelial cells; predicted type II membrane protein of FT Golgi; fungal-specific" FT CDS complement(395525..397120) FT /gene="orf19.1666" FT /Ca19Contig="Ca19-10123|129401..130996" FT /synonym="orf19.9235, IPF25623.1, IPF6310.1, Contig4- FT 3069_0012, orf6.5741, CA3470" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; FT transcription is induced in response to alpha pheromone in FT SpiderM medium" FT CDS complement(391164..394916) FT /gene="orf19.1667" FT /Ca19Contig="Ca19-10123|131605..135357" FT /synonym="orf19.9236, IPF25699.1, IPF6308.2, Contig4- FT 3069_0013, Contig4-3069_0015, orf6.5742, CA3471" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(390685..390951) FT /gene="orf19.1667.1" FT /Ca19Contig="Ca19-10123|135570..135836" FT /synonym="IPF25704.1, IPF6306.1, Contig4-3069_0016, FT CA3472" FT /remarks="ORF Predicted by Annotation Working Group" FT CDS complement(388591..390462) FT /gene="orf19.1668" FT /Ca19Contig="Ca19-10123|136059..137930" FT /synonym="orf19.9237, IPF25608.1, IPF6305.2, Contig4- FT 3069_0018, orf6.5743, CA3473" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; FT decreased expression observed in an ssr1 homozygous null FT mutant; possibly spurious ORF (Annotation Working Group FT prediction)" FT CDS 386035..388422 FT /gene="orf19.1669" FT /Ca19Contig="Ca19-10123|complement(138099..140486)" FT /synonym="orf19.9238, IPF25597.1, IPF8090.2, Contig4- FT 3069_0019, orf6.5744, CA3474" FT /remarks="Protein likely to be essential for growth, based FT on an insertional mutagenesis strategy; similar to S. FT cerevisiae Afg3p, which is a subunit of the mitochondrial FT inner membrane m-AAA protease" FT CDS complement(382408..385245) FT /gene="orf19.1670" FT /Ca19Contig="Ca19-10123|141276..144113" FT /synonym="orf19.9239, IPF25590.1, IPF8087.2, Contig4- FT 3069_0020, orf6.5745, CA3475" FT /remarks="Protein involved in transport from FT multivesicular body to vacuole; similar to S. cerevisiae FT Bro1p, which is a class E vacuolar protein sorting (VPS) FT factor; not involved in RIM101 pathway; FT macrophage/pseudohyphal-repressed" FT CDS complement(376776..378188) FT /gene="orf19.1671" FT /Ca19Contig="Ca19-10123|148333..149745" FT /synonym="orf19.9240, orf6.1639, IPF8080.2, IPF29345.1, FT Contig4-3069_0027, CA0605" FT /remarks="Putative glycosidase; cell wall; role in FT adhesion; required for hyphal growth on Spider (not serum) FT medium; chitin-binding, glycosyl hydrolase, GPI anchor FT domains; induced during cell wall regeneration; mRNA FT detected in yeast-form cells" FT CDS complement(372617..376282) FT /gene="orf19.1672" FT /Ca19Contig="Ca19-10123|150239..153904" FT /synonym="orf19.9241, IPF8079.2, IPF29375.1, Contig4- FT 3069_0031, orf6.1640, CA0606" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(370316..372010) FT /gene="orf19.1673" FT /Ca19Contig="Ca19-10123|154511..156205" FT /synonym="orf19.9242, orf6.1084, IPF25613.1, IPF14222.3, FT Contig4-2335_0002, CA0298" FT /remarks="Protein described as serine/threonine FT phosphatase; transcriptionally regulated by iron; FT expression greater in high iron" FT CDS 367758..370016 FT /gene="orf19.1674" FT /Ca19Contig="Ca19-10123|complement(156505..158763)" FT /synonym="orf19.9243, IPF25604.1, IPF14223.1, Contig4- FT 2335_0001, orf6.1083, CA0297" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 365731..366933 FT /gene="orf19.1675" FT /Ca19Contig="Ca19-10123|complement(159588..160790)" FT /synonym="orf19.9244, IPF14225.2, IPF29346.1, Contig4- FT 2335_0007, orf6.1997, CA0832" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS join(complement(363956..364222), FT complement(363116..363934)) FT /gene="orf19.1676" FT /Ca19Contig="Ca19-10123|join(162299..162565,162587..163405) FT " FT /synonym="orf19.9245, IPF12502.2, IPF12501.2, IPF29330.1, FT IPF29350.1, Contig4-2527_0003, Contig4-2527_0005, FT orf6.1998, CA0833" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 361020..361817 FT /gene="orf19.1677" FT /Ca19Contig="Ca19-10123|complement(164704..165549)" FT /synonym="orf19.9246, IPF25645.1, IPF12499.2, Contig4- FT 2527_0007, orf6.1999, CA0834" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; FT possibly spurious ORF (Annotation Working Group FT prediction)" FT CDS 360591..360941 FT /gene="orf19.1678" FT /Ca19Contig="Ca19-10123|complement(165580..165930)" FT /synonym="orf19.9247, Contig4-2527_0008, orf6.2000" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(358585..359514) FT /gene="orf19.1679" FT /Ca19Contig="Ca19-10123|166899..167936" FT /synonym="orf19.9248, IPF12495.1, IPF29348.1, Contig4- FT 2527_0011, orf6.2001, CA0836" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS join(356355..356357,356435..357607,357640..358287) FT /gene="orf19.1680" FT /Ca19Contig="Ca19-10123|complement(join(170164..170166,1689 FT 33..170086,168234..168867))" FT /synonym="orf19.9249, IPF12493.1, IPF29347.1, IPF29353.1, FT Contig4-2527_0012, orf6.2002, CA0838" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 355411..355971 FT /gene="orf19.1681" FT /Ca19Contig="Ca19-10123|complement(170550..171110)" FT /synonym="orf19.9250, IPF25657.1, IPF11682.3, Contig4- FT 2363_0001, Contig4-2527_0013, orf6.2003, orf6.888, CA0839" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 353984..355144 FT /gene="orf19.1682" FT /Ca19Contig="Ca19-10123|complement(171377..172537)" FT /synonym="orf19.9251, IPF25637.1, IPF11681.2, Contig4- FT 2363_0002, orf6.889, CA0216" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; FT repressed by nitric oxide" FT CDS 352215..353297 FT /gene="orf19.1683" FT /Ca19Contig="Ca19-10123|complement(173224..174306)" FT /synonym="orf19.9252, IPF11679.2, IPF11680.3, Contig4- FT 2363_0004, orf6.1330, orf6.890, CA0425" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; FT caspofungin repressed" FT CDS 349629..351311 FT /gene="orf19.1684" FT /Ca19Contig="Ca19-10123|complement(175210..176892)" FT /synonym="orf19.9253, IPF11676.2, IPF29339.1, Contig4- FT 2363_0007, orf6.4155, orf6.1329, CA2307" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 348158..349507 FT /gene="orf19.1685" FT /Ca19Contig="Ca19-10123|complement(177014..178363)" FT /synonym="IPF6510.2, orf6.4154, CA2306" FT /remarks="Predicted zinc-finger protein of unknown FT function" FT CDS 345803..347512 FT /gene="orf19.1686" FT /Ca19Contig="Ca19-10123|complement(179009..180718)" FT /synonym="orf19.9254, IPF25619.1, IPF6511.1, Contig4- FT 2909_0002, orf6.4153, CA2305" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 343054..345357 FT /gene="orf19.1687" FT /Ca19Contig="Ca19-10123|complement(181164..183467)" FT /synonym="orf19.9255, IPF25600.1, IPF6512.1, Contig4- FT 2909_0003, orf6.4152, CA2304" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(337288..338694) FT /gene="orf19.1690" FT /Ca19Contig="Ca19-10123|187827..189233" FT /synonym="orf19.9258, IPF25628.1, IPF6517.2, Contig4- FT 2909_0012, orf6.4149, CA2303" FT /remarks="Protein described as similar to alpha agglutinin FT anchor subunit; exogenously expressed protein is a FT substrate for Kex2p processing in vitro; fluconazole- FT induced; transcription is induced in response to alpha FT pheromone in SpiderM medium" FT CDS 336242..336829 FT /gene="orf19.1691" FT /Ca19Contig="Ca19-10123|complement(189692..190279)" FT /synonym="orf19.9259, IPF19200.1, IPF6518.1, Contig4- FT 2909_0014, orf6.4148, orf6.653, CA2302" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; FT fluconazole-induced; filament induced; Hog1p-induced; FT regulated by Nrg1p, Tup1p" FT CDS join(complement(326199..333137), FT complement(324644..326197)) FT /gene="orf19.1693" FT /Ca19Contig="Ca19-10123|join(193384..200322,200324..201877) FT " FT /synonym="orf19.9261, IPF25646.1, IPF29342.1, IPF6521.3, FT Contig4-2861_0008, Contig4-2861_0009, Contig4-2861_0010, FT Contig4-2869_0015, orf6.3035, orf6.4146, CA2301, CA6262, FT orf19.1694" FT /remarks="Protein similar to S. cerevisiae Tao3p; FT essential for viability; insertion mutation near 3' end of FT gene causes increase in caspofungin sensitivity; FT transcription is induced in response to alpha pheromone in FT SpiderM medium" FT CDS complement(323313..324374) FT /gene="orf19.1697" FT /Ca19Contig="Ca19-10123|202147..203208" FT /synonym="orf19.9264, IPF25640.1, IPF13221.2, Contig4- FT 2869_0013, orf6.3038, CA1500" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 321288..323186 FT /gene="orf19.1698" FT /Ca19Contig="Ca19-10123|complement(203335..205233)" FT /synonym="orf19.9265, IPF13217.2, IPF13660.3, Contig4- FT 2869_0012, orf6.3039, orf6.375, CA1501" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(318643..320505) FT /gene="orf19.1699" FT /Ca19Contig="Ca19-10123|206016..207878" FT /synonym="orf19.9266, IPF25611.1, IPF13661.3, Contig4- FT 2869_0011, orf6.3040, orf6.374, CA0060" FT /remarks="Protein similar to S. cerevisiae Bzz1p, FT which is an SH3 domain protein involved in the regulation FT of actin polymerization" FT CDS 317804..318364 FT /gene="orf19.1700" FT /Ca19Contig="Ca19-10123|complement(208157..208717)" FT /synonym="orf19.9267, IPF13662.1, IPF29352.1, Contig4- FT 2869_0009, orf6.3041, CA1502" FT /remarks="Predicted ribosomal protein; genes encoding FT cytoplasmic ribosomal subunits, translation factors, and FT tRNA synthetases are downregulated upon phagocytosis by FT murine macrophage" FT CDS complement(316415..317137) FT /gene="orf19.1701" FT /Ca19Contig="Ca19-10123|209315..210106" FT /synonym="orf19.9268, IPF13663.2, IPF29351.1, Contig4- FT 2869_0008, orf6.3042, CA1503" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS join(315541..315555,315669..316181) FT /gene="orf19.1702" FT /Ca19Contig="Ca19-10123|complement(210340..210828)" FT /synonym="orf19.9269, IPF25666.1, IPF13664.2, Contig4- FT 2869_0006, orf6.3043, CA1504" FT /remarks="Transcription is filament induced; Tup1p FT regulated (see Locus History Note for Assembly 19 FT correction)" FT CDS complement(311915..313147) FT /gene="orf19.1704" FT /Ca19Contig="Ca19-10123|213374..214606" FT /synonym="orf19.9271, IPF17552.3, IPF16087.1, POT1-1, FT Contig4-2869_0003, orf6.3123, CA1561" FT /remarks="Putative peroxisomal 3-oxoacyl CoA thiolase; FT expression is regulated upon white-opaque switching" FT CDS complement(308341..311610) FT /gene="orf19.1706" FT /Ca19Contig="Ca19-10123|214911..218180" FT /synonym="orf19.9273, IPF25707.1, IPF16088.2, Contig4- FT 2424_0011, orf6.3121, CA1560" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; Plc1p- FT regulated" FT CDS complement(308008..308325) FT /gene="orf19.1707" FT /Ca19Contig="Ca19-10123|218196..218513" FT /synonym="orf19.9274, IPF25708.1, IPF16535.2, Contig4- FT 2424_0001, orf6.3120" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 307190..307849 FT /gene="orf19.1708" FT /Ca19Contig="Ca19-10123|complement(218672..219331)" FT /synonym="orf19.9275, IPF25649.1, IPF16533.2, Contig4- FT 2424_0002, orf6.3119, CA1559" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(305161..305544) FT /gene="orf19.1709" FT /Ca19Contig="Ca19-10123|220977..221360" FT /synonym="orf19.9276, IPF25694.1, IPF15679.2, Contig4- FT 2424_0007, orf6.3118, CA1558" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; FT alkaline downregulated; shows colony morphology-related FT gene regulation by Ssn6p" FT CDS complement(303150..303989) FT /gene="orf19.1710" FT /Ca19Contig="Ca19-10123|222532..223371" FT /synonym="orf19.9277, IPF25643.1, IPF15677.2, Contig4- FT 2424_0009, orf6.3117, CA1557" FT /remarks="Protein described as NADH-ubiquinone FT oxidoreductase; identified in detergent-resistant membrane FT fraction (possible lipid raft component); predicted N- FT terminal acetylation; repressed by nitric oxide" FT CDS 301882..303069 FT /gene="orf19.1711" FT /Ca19Contig="Ca19-10123|complement(223452..224639)" FT /synonym="orf19.9278, IPF25635.1, IPF15676.2, orf6.3116, FT CA1556" FT /remarks="Regulated by Gcn4p; induced in response to amino FT acid starvation (3-aminotriazole treatment)" FT CDS join(complement(300304..300640), FT complement(297256..300302)) FT /gene="orf19.1712" FT /Ca19Contig="Ca19-10123|join(225881..226216,226218..229265) FT " FT /synonym="orf19.9279, orf19.9280, orf6.3114, IPF25656.1, FT IPF25714.1, IPF14074.1, IPF14077.1, Contig4-2180_0007, FT orf6.3115, CA1555, CA1554, orf19.1713" FT /remarks="Protein described as an ARF GTP/GDP exchange FT factor; transcriptionally regulated by iron; expression FT greater in low iron" FT CDS complement(294820..295743) FT /gene="orf19.1714" FT /Ca19Contig="Ca19-10123|230778..231701" FT /synonym="orf19.9282, IPF25662.1, IPF14081.2, orf6.3113, FT orf6.4847, orf6.4846, CA1553" FT /remarks="Putative GPI-anchored protein of unknown FT function" FT CDS complement(291947..293737) FT /gene="orf19.1715" FT /Ca19Contig="Ca19-10123|232784..234574" FT /synonym="orf19.9283, orf6.4843, IPF11363.1, IPF29338.1, FT Contig4-2578_0004, Contig4-2578_0006, orf6.4845, CA2802" FT /remarks="Putative transcription factor; role in iron FT utilization, pathogenesis; both IRO1 and adjacent URA3 are FT mutated in strain CAI4; suppresses S. cerevisiae aft1 FT mutant low-iron growth defect; hyphal-induced; reports FT differ about iron regulation" FT CDS complement(290699..291511) FT /gene="orf19.1716" FT /Ca19Contig="Ca19-10123|235010..235822" FT /synonym="orf19.9284, IPF25647.1, IPF11364.1, Contig4- FT 2578_0003, orf6.4844, CA2801" FT /remarks="Orotidine-5'-phosphate decarboxylase, enzyme of FT pyrimidine biosynthesis; gene used as a molecular genetic FT marker, but decreased expression when integrated at FT ectopic chromosomal locations can cause defects in hyphal FT growth and virulence" FT CDS 289159..290544 FT /gene="orf19.1717" FT /Ca19Contig="Ca19-10123|complement(235977..237362)" FT /synonym="orf19.9285, orf6.4843, IPF25627.1, IPF11366.2, FT Contig4-2578_0002, CA2800" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 285854..288601 FT /gene="orf19.1718" FT /Ca19Contig="Ca19-10123|complement(237920..240667)" FT /synonym="orf19.9286, IPF25589.1, IPF19769.1, orf6.4842, FT CA2799" FT /remarks="Predicted zinc-finger protein of unknown FT function; decreased transcription is observed upon FT fluphenazine treatment" FT CDS complement(280851..282545) FT /gene="orf19.1719" FT /Ca19Contig="Ca19-10123|243976..245670" FT /synonym="orf19.9287, IPF25618.1, IPF8402.2, Contig4- FT 2981_0019, orf6.4841, CA2798" FT /remarks="Putative glucoamylase; fungal-specific (no human FT or murine homolog)" FT CDS 277914..280508 FT /gene="orf19.1720" FT /Ca19Contig="Ca19-10123|complement(246013..248607)" FT /synonym="orf19.9288, IPF25592.1, IPF8404.1, Contig4- FT 2981_0018, orf6.4840, CA2797" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(276072..276917) FT /gene="orf19.1721" FT /Ca19Contig="Ca19-10123|249604..250449" FT /synonym="orf19.9289, IPF25642.1, IPF8405.1, Contig4- FT 2981_0017, orf6.4839, CA2796" FT /remarks="Carbonic anhydrase involved in the conversion of FT carbon dioxide to bicarbonate; essential for pathogenesis FT in host niches with limited CO2; induced upon biofilm FT formation; transcriptionally activated by Mnl1p under weak FT acid stress" FT CDS 275813..276229 FT /gene="orf19.1722" FT /Ca19Contig="Ca19-10123|complement(250292..250708)" FT /synonym="orf19.9290, IPF25679.1, IPF29361.1, orf6.4838" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 274966..275634 FT /gene="orf19.1723" FT /Ca19Contig="Ca19-10123|complement(250887..251555)" FT /synonym="orf19.9291, IPF25651.1, IPF8407.1, Contig4- FT 2981_0015, orf6.4837, CA2795" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 274279..274746 FT /gene="orf19.1724" FT /Ca19Contig="Ca19-10123|complement(251775..252242)" FT /synonym="orf19.9292, IPF25671.1, IPF8408.1, Contig4- FT 2981_0013, orf6.4836, CA2794" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; FT induced by nitric oxide in yhb1 mutant" FT CDS complement(269783..271960) FT /gene="orf19.1725" FT /Ca19Contig="Ca19-10123|254561..256738" FT /synonym="orf19.9293, IPF8416.3, IPF9336.3, Contig4- FT 2981_0008, orf6.3240, CA1646" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 265343..268978 FT /gene="orf19.1727" FT /Ca19Contig="Ca19-10123|complement(257543..261178)" FT /synonym="orf19.9295, IPF25700.1, IPF9340.1, Contig4- FT 2981_0007, orf6.3238, CA1645" FT /remarks="Vacuolar calcium P-type ATPase; transcription is FT regulated by calcineurin and fluconazole; mutant shows FT increased resistance to fluconazole or lithium, and FT increased sensitivity to calcium" FT CDS complement(261302..261934) FT /gene="orf19.1728" FT /Ca19Contig="Ca19-10123|264587..265219" FT /synonym="orf19.9296, IPF25653.1, IPF9345.1, Contig4- FT 1881_0002, orf6.3237, CA1644" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 260259..261266 FT /gene="orf19.1729" FT /Ca19Contig="Ca19-10123|complement(265255..266262)" FT /synonym="orf19.9297, IPF25625.1, IPF9347.2, Contig4- FT 1881_0001, orf6.3236, CA1643" FT /remarks="Putative transcription factor with zinc finger FT DNA-binding motif; possibly spurious ORF (Annotation FT Working Group prediction)" FT CDS join(complement(258979..259018),complement(258402..258904), FT complement(258008..258403)) FT /gene="orf19.1730" FT /Ca19Contig="Ca19-10123|join(267503..267542,267617..268119, FT 268118..268513)" FT /synonym="orf19.9298, orf19.9299, IPF25677.1, IPF25664.1, FT IPF9350.2, IPF9349.2, orf6.3235, orf6.3234, CA1642, FT CA1641, orf19.1731" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(526942..527271) FT /gene="orf19.227" FT /Ca19Contig="Ca19-10046|complement(149..478)" FT /synonym="orf19.7857, IPF27081.1, IPF15250.2, Contig4- FT 2074_0001, orf6.215, CA0031" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; FT flucytosine induced; repressed by nitric oxide" FT CDS join(complement(529186..529188), FT complement(527654..528904)) FT /gene="orf19.229" FT /Ca19Contig="Ca19-10046|complement(810..1988)" FT /synonym="orf19.7859, IPF27020.1, IPF15248.2, Contig4- FT 2074_0003, orf6.217, CA0032" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(529720..532362) FT /gene="orf19.230" FT /Ca19Contig="Ca19-10046|complement(2876..5518)" FT /synonym="orf19.7860, IPF26959.1, IPF15244.3, Contig4- FT 2074_0005, Contig4-2074_0006, orf6.1121, orf6.1122, FT orf6.218, CA0320" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 533181..535505 FT /gene="orf19.231" FT /Ca19Contig="Ca19-10046|6337..8661" FT /synonym="orf19.7861, IPF15242.2, IPF29874.1, Contig4- FT 2074_0008, orf6.1123, orf6.518, CA0321" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(535616..536530) FT /gene="orf19.232" FT /Ca19Contig="Ca19-10046|complement(8772..9686)" FT /synonym="orf19.7862, IPF19038.2, IPF10105.2, Contig4- FT 2868_0002, Contig4-2868_0003, orf6.1124, orf6.519, CA0101" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS join(536985..537018,537093..537430) FT /gene="orf19.233.1" FT /Ca19Contig="Ca19-10046|join(10141..10174,10249..10586)" FT /synonym="IPF19089.2, IPF10102.1, Contig4-2868_0004, FT Contig4-2868_0005" FT /remarks="Protein similar to S. cerevisiae Hrt1p, which is FT a component of a nuclear ubiquitin-protein ligase complex FT involved in cell cycle control; induced under hydroxyurea FT treatment" FT CDS join(complement(538647..538697), FT complement(537690..538568)) FT /gene="orf19.234" FT /Ca19Contig="Ca19-10046|complement(join(11803..11853,10846. FT .11724))" FT /synonym="orf19.7864, IPF10101.2, IPF19241.1, PHA2.3, FT Contig4-2868_0006, orf6.953, orf6.521, CA0238" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; FT decreased expression observed in an ssr1 homozygous null FT mutant" FT CDS complement(539398..539973) FT /gene="orf19.236" FT /Ca19Contig="Ca19-10046|complement(12554..13129)" FT /synonym="orf19.7866, IPF27046.1, IPF10099.1, Contig4- FT 2868_0008, orf6.955, CA0239" FT /remarks="Predicted ribosomal protein; genes encoding FT cytoplasmic ribosomal subunits, translation factors, and FT tRNA synthetases are downregulated upon phagocytosis by FT murine macrophage; repressed by nitric oxide" FT CDS complement(540452..541552) FT /gene="orf19.238" FT /Ca19Contig="Ca19-10046|complement(13608..14708)" FT /synonym="orf19.7868, orf6.957, orf6.2684, IPF10098.1, FT IPF18721.2, Contig4-2868_0011, CA6170" FT /remarks="Similar to cytochrome-c peroxidase N terminus; FT transcription is negatively regulated by Rim101p or FT alkaline pH; transcription induced by interaction with FT macrophage or low iron; oxygen-induced activity" FT CDS complement(542737..546648) FT /gene="orf19.239" FT /Ca19Contig="Ca19-10046|complement(15893..19804)" FT /synonym="orf19.7869, IPF27079.1, IPF10096.2, Contig4- FT 2868_0013, orf6.2685, CA1264" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; FT induced by nitric oxide" FT CDS 547789..548346 FT /gene="orf19.240" FT /Ca19Contig="Ca19-10046|20852..21502" FT /synonym="orf19.7870, IPF27040.1, IPF10510.2, Contig4- FT 2868_0015, orf6.2686, CA1265" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(548703..549920) FT /gene="orf19.242" FT /Ca19Contig="Ca19-10046|complement(21859..23076)" FT /synonym="orf19.7872, IPF27022.1, IPF10508.1, Contig4- FT 2868_0016, orf6.2688, CA1266" FT /remarks="Secreted aspartyl proteinase; regulated by FT growth phase, temperature, and white-opaque switch; highly FT expressed in opaque cells; expressed upon deep epidermal FT invasion; greater expression during vaginal infection than FT oral infection" FT CDS 552111..552299 FT /gene="orf19.242.2" FT /Ca19Contig="Ca19-10046|25267..25455" FT /synonym="IPF10503.2, CA1267" FT /remarks="ORF Predicted by Annotation Working Group" FT CDS complement(552865..553902) FT /gene="orf19.243" FT /Ca19Contig="Ca19-10046|complement(26021..27058)" FT /synonym="orf19.7873, IPF10502.1, IPF18720.2, Contig4- FT 2680_0004, orf6.1270, orf6.2689, CA6171" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(554245..554943) FT /gene="orf19.244" FT /Ca19Contig="Ca19-10046|complement(27401..28099)" FT /synonym="orf19.7874, IPF27037.1, IPF10499.2, Contig4- FT 2680_0006, orf6.1271, CA0390" FT /remarks="Transcription is regulated by Nrg1p and Mig1p" FT CDS 555138..556604 FT /gene="orf19.245" FT /Ca19Contig="Ca19-10046|28294..29760" FT /synonym="orf19.7875, IPF10496.2, IPF17370.2, Contig4- FT 2680_0007, Contig4-2680_0008, orf6.1272, orf6.602, CA0391" FT /remarks="Transcription is induced during filamentous FT growth; regulated by Nrg1p, Tup1p" FT CDS 557138..559369 FT /gene="orf19.246" FT /Ca19Contig="Ca19-10046|30294..32525" FT /synonym="orf19.7877, IPF17369.3, IPF10495.2, Contig4- FT 2680_0011, orf6.1273, orf6.1996, orf6.601, CA0129" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; FT fungal-specific (no human or murine homolog)" FT CDS complement(559366..560097) FT /gene="orf19.247" FT /Ca19Contig="Ca19-10046|complement(32522..33253)" FT /synonym="orf19.7878, IPF14701.2, IPF10493.3, Contig4- FT 2680_0012, orf6.1995, orf6.600, CA0831" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 560381..563680 FT /gene="orf19.248" FT /Ca19Contig="Ca19-10046|33537..36836" FT /synonym="orf19.7879, IPF14699.2, IPF29913.1, Contig4- FT 1809_0004, orf6.1994, CA0830" FT /remarks="Protein not essential for viability; similar to FT S. cerevisiae Apl5p, which is a subunit of the AP-3 FT adaptor complex involved in Golgi-to-vacuole transport" FT CDS 189566..190363 FT /gene="orf19.2496" FT /Ca19Contig="Ca19-10150|123725..124522" FT /synonym="orf19.10032, IPF24862.1, IPF4026.2, IPF18376.1, FT Contig4-2897_0002, orf6.6177, CA3813, CA3154, FT orf19.6169.2" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; FT fluconazole-downregulated" FT CDS 191434..193119 FT /gene="orf19.2498" FT /Ca19Contig="Ca19-10150|125542..127227" FT /synonym="orf19.10034, IPF24833.1, IPF4023.2, Contig4- FT 2897_0001, orf6.6179, CA3814" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; FT oxidative stress-induced via Cap1p" FT CDS complement(193325..194449) FT /gene="orf19.2499" FT /Ca19Contig="Ca19-10150|complement(127433..128557)" FT /synonym="orf19.10035, IPF24849.1, IPF4018.2, orf6.6180, FT CA3815" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(563890..564771) FT /gene="orf19.250" FT /Ca19Contig="Ca19-10046|complement(37046..37927)" FT /synonym="orf19.7881, IPF27028.1, IPF19886.1, Contig4- FT 1809_0003, orf6.1992, CA0829" FT /remarks="Protein repressed during the mating process" FT CDS 194589..195731 FT /gene="orf19.2500" FT /Ca19Contig="Ca19-10150|128697..129839" FT /synonym="orf19.10036, IPF24848.1, IPF4017.2, Contig4- FT 2453_0012, orf6.6181, CA3816" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 198962..201388 FT /gene="orf19.2501" FT /Ca19Contig="Ca19-10150|133070..135496" FT /synonym="orf19.10037, IPF17613.3, IPF4012.2, Contig4- FT 2453_0003, orf6.2324, orf6.6182, CA1039" FT /remarks="Protein involved in heme uptake; putative FAD FT transporter, similar to S. cerevisiae Flc1p; regulated by FT iron; macrophage-induced gene; mutant shows defect in FT filamentous growth" FT CDS complement(201600..202856) FT /gene="orf19.2503" FT /Ca19Contig="Ca19-10150|complement(135708..136964)" FT /synonym="orf19.10039, IPF24842.1, IPF4010.2, Contig4- FT 2453_0001, Contig4-2453_0002, orf6.2326, CA1040" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 203106..206738 FT /gene="orf19.2504" FT /Ca19Contig="Ca19-10150|137214..140846" FT /synonym="orf19.10040, IPF24887.1, IPF4009.2, Contig4- FT 2895_0007, orf6.2327, CA1041" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; FT flucytosine induced" FT CDS 206840..207148 FT /gene="orf19.2505" FT /Ca19Contig="Ca19-10150|140948..141256" FT /synonym="orf19.10041, IPF24893.1, IPF29103.1, orf6.2328, FT orf6.3910" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 209984..211777 FT /gene="orf19.2506" FT /Ca19Contig="Ca19-10150|144092..145885" FT /synonym="orf19.10042, IPF16841.2, IPF18784.2, Contig4- FT 2657_0017, orf6.2329, orf6.3911, CA1042" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; FT opaque-specific transcription; Hog1p-downregulated" FT CDS 212192..213646 FT /gene="orf19.2507" FT /Ca19Contig="Ca19-10150|146300..147754" FT /synonym="orf19.10043, IPF24839.1, IPF15652.2, Contig4- FT 2657_0015, Contig4-2657_0016, orf6.3912, CA2137" FT /remarks="Protein likely to be essential for growth, based FT on an insertional mutagenesis strategy; similar to S. FT cerevisiae Arp3p, which is a component of the Arp2/3 FT complex involved in actin-dependent processes" FT CDS join(complement(215097..215620), FT complement(213866..215024)) FT /gene="orf19.2508" FT /Ca19Contig="Ca19-10150|complement(147974..148891)" FT /synonym="orf19.10044, IPF24846.1, IPF15653.2, Contig4- FT 2657_0014, orf6.3913, CA2139" FT /remarks="Protein not essential for viability; similar to FT S. cerevisiae Prm9p, which may bind to COPII coated FT vesicles" FT CDS complement(215093..215620) FT /gene="orf19.2509" FT /Ca19Contig="Ca19-10150|complement(149201..149728)" FT /synonym="orf19.10045, IPF24867.1, IPF15654.2, Contig4- FT 2657_0013, orf6.3914" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(565707..566417) FT /gene="orf19.251" FT /Ca19Contig="Ca19-10046|complement(38863..39573)" FT /synonym="orf19.7882, orf6.1991, IPF17186, IPF17186.2, FT IPF29885.1, Contig4-1809_0005, YDR533C, CA0828" FT /remarks="Member of ThiJ/PfpI protein family; antigenic FT (Cand a 3 allergen); binds human immunoglobulin E; 2 N- FT glycosylation motifs; alkaline, fluconazole, Hog1p- FT downregulated; induced in core stress response or by FT oxidative stress (via Cap1p); possibly benomyl induced" FT CDS join(complement(218996..220223), FT complement(217232..218997)) FT /gene="orf19.2510" FT /Ca19Contig="Ca19-10150|complement(join(153105..154343,1513 FT 40..153106))" FT /synonym="orf19.10046, orf19.10047, IPF19665.1, FT IPF19664.1, IPF29081.1, IPF29083.1, Contig4-2657_0003, FT Contig4-2657_0004, Contig4-2657_0005, orf6.3915, FT orf6.3916, CA2140, CA2141, orf19.2511" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 220532..220822 FT /gene="orf19.2511.1" FT /Ca19Contig="Ca19-10150|154640..154930" FT /synonym="IPF15872.2, IPF19409.2, Contig4-2657_0002, FT CA2142" FT /remarks="ORF Predicted by Annotation Working Group; FT increased expression observed in an ssr1 homozygous null FT mutant" FT CDS 223161..223820 FT /gene="orf19.2512" FT /Ca19Contig="Ca19-10150|157269..157928" FT /synonym="orf19.10048, IPF12803.2, IPF29085.1, Contig4- FT 1978_0003, orf6.3917, CA2143" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; FT possibly spurious ORF (Annotation Working Group FT prediction)" FT CDS complement(223900..226050) FT /gene="orf19.2513" FT /Ca19Contig="Ca19-10150|complement(158008..160158)" FT /synonym="orf19.10049, IPF24827.1, IPF12802.2, Contig4- FT 1978_0004, Contig4-1978_0006, orf6.3918, CA2144" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 226288..227349 FT /gene="orf19.2514" FT /Ca19Contig="Ca19-10150|160396..161457" FT /synonym="orf19.10050, IPF24853.1, IPF12800.1, Contig4- FT 2437_0007, orf6.3919, CA2145" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(227682..230336) FT /gene="orf19.2515" FT /Ca19Contig="Ca19-10150|complement(161790..164444)" FT /synonym="orf19.10051, IPF24819.1, IPF12799.2, orf6.3920, FT CA2146" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 231624..232868 FT /gene="orf19.2516" FT /Ca19Contig="Ca19-10150|165724..166386" FT /synonym="orf19.10052, IPF24860.1, IPF18533.1, orf6.3921, FT CA2147" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(568165..568518) FT /gene="orf19.252" FT /Ca19Contig="Ca19-10046|complement(41321..41674)" FT /synonym="orf19.7884, orf19.7885, IPF18859.2, IPF29889.1, FT orf6.1989, orf6.1988, orf19.253" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(569249..570517) FT /gene="orf19.254" FT /Ca19Contig="Ca19-10046|complement(42405..43673)" FT /synonym="orf19.7886, IPF18861.2, IPF16370.2, Contig4- FT 2723_0001, orf6.1987, orf6.691, CA0152" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; Hog1p- FT downregulated" FT CDS complement(570730..573246) FT /gene="orf19.255" FT /Ca19Contig="Ca19-10046|complement(43886..46402)" FT /synonym="orf19.7887, IPF26971.1, IPF16368.2, Contig4- FT 2723_0002, Contig4-2723_0003, Contig4-2723_0004, orf6.692, FT CA0153" FT /remarks="Predicted zinc-cluster protein of unknown FT function; possibly transcriptionally regulated upon hyphal FT formation; intron in 5'-UTR" FT CDS 573405..573731 FT /gene="orf19.257" FT /Ca19Contig="Ca19-10046|46561..46887" FT /synonym="orf19.7889, orf6.694, orf6.1190, IPF27080.1, FT IPF29899.1" FT /remarks="Transcription is negatively regulated by Sfu1p; FT repressed by nitric oxide" FT CDS 577094..577852 FT /gene="orf19.258" FT /Ca19Contig="Ca19-10046|50250..51008" FT /synonym="orf19.7890, IPF15540.1, IPF13725.1, Contig4- FT 2723_0007, orf6.1191, orf6.1453, CA0486" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 578229..578984 FT /gene="orf19.259" FT /Ca19Contig="Ca19-10046|51385..52140" FT /synonym="orf19.7891, IPF19234.2, IPF13724.1, Contig4- FT 2723_0008, orf6.1454, CA0487" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(579112..580713) FT /gene="orf19.260" FT /Ca19Contig="Ca19-10046|complement(52268..54022)" FT /synonym="orf19.7892, IPF13723.2, IPF29880.1, Contig4- FT 2723_0009, orf6.1455, orf6.548, CA0109" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(581351..583111) FT /gene="orf19.261" FT /Ca19Contig="Ca19-10046|complement(54507..56267)" FT /synonym="orf19.7894, IPF12686.3, IPF13722.2, Contig4- FT 2723_0010, orf6.1456, orf6.2014, orf6.549, CA0488" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS join(583699..586771,586891..587405) FT /gene="orf19.262" FT /Ca19Contig="Ca19-10046|join(56855..59926,60046..60561)" FT /synonym="orf19.7895, IPF12682.2, IPF18780.2, IPF18779.1, FT Contig4-2723_0011, orf6.2013, orf6.2357, orf6.2358, FT CA0846, CA6315, orf19.263" FT /remarks="Protein likely to be essential for growth, based FT on an insertional mutagenesis strategy; similar to S. FT cerevisiae Smc3p, which is an ATPase involved in sister FT chromatid cohesion" FT CDS join(588934..588936,589555..589764) FT /gene="orf19.263.1" FT /remarks="Predicted ORF in Assembly 20 and 21; gene has FT intron" FT CDS 590983..592335 FT /gene="orf19.264" FT /Ca19Contig="Ca19-10046|64139..65491" FT /synonym="orf19.7896, IPF16314.2, IPF29883.1, Contig4- FT 2401_0007, Contig4-2401_0009, orf6.2012, orf6.2359, FT CA0845" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; FT possibly spurious ORF (Annotation Working Group FT prediction)" FT CDS 594341..595843 FT /gene="orf19.265" FT /Ca19Contig="Ca19-10046|67497..68999" FT /synonym="orf19.7897, IPF27009.1, IPF16342.2, Contig4- FT 2401_0010, orf6.2360, CA6172" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; FT possibly spurious ORF (Annotation Working Group FT prediction)" FT CDS complement(596210..599851) FT /gene="orf19.267" FT /Ca19Contig="Ca19-10046|complement(69366..73007)" FT /synonym="orf19.7899, IPF19341.2, IPF11460.2, orf6.2362, FT CA1060" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(600170..601513) FT /gene="orf19.268" FT /Ca19Contig="Ca19-10046|complement(73326..74669)" FT /synonym="orf19.7900, IPF11452.2, IPF9532.3, Contig4- FT 2183_0007, Contig4-2524_0002, orf6.2363, orf6.3181, FT CA1599" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 601817..603193 FT /gene="orf19.269" FT /Ca19Contig="Ca19-10046|74973..76349" FT /synonym="orf19.7901, IPF9534.2, IPF18778.2, Contig4- FT 2183_0004, orf6.3180, CA1598" FT /remarks="Seryl-tRNA synthetase; charges the tRNA that FT recognizes the CUG codon, which typically specifies Leu, FT but specifies Ser in C. albicans; complements S. FT cerevisiae ses1 mutant viability; soluble protein in FT hyphae; macrophage-regulated" FT CDS 603615..603929 FT /gene="orf19.270" FT /Ca19Contig="Ca19-10046|76771..77085" FT /synonym="orf19.7902, IPF27092.1, IPF9536.2, Contig4- FT 2183_0003, orf6.3179" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 604669..605445 FT /gene="orf19.271" FT /Ca19Contig="Ca19-10046|77825..78601" FT /synonym="orf19.7903, IPF9538, Contig4-2183_0001, FT IPF27033.1, IPF9538.2, Contig4-2499_0006, orf6.3178, FT CA1597" FT /remarks="Protein not essential for viability; FT transcription is increased in an azole-resistant strain FT overexpressing MDR1; transcription is increased in FT populations of cells exposed to fluconazole over multiple FT generations" FT CDS complement(605651..607807) FT /gene="orf19.272" FT /Ca19Contig="Ca19-10046|complement(78807..80963)" FT /synonym="orf19.7904, IPF26977.1, IPF9539.2, Contig4- FT 2499_0005, orf6.3177, CA1596, FAA2-2" FT /remarks="Predicted acyl CoA synthetase; upregulated upon FT phagocytosis; transcription is regulated by Nrg1p and FT Mig1p" FT CDS complement(610541..611548) FT /gene="orf19.273" FT /Ca19Contig="Ca19-10046|complement(83697..84704)" FT /synonym="orf19.7905, IPF9544.2, IPF29884.1, Contig4- FT 2499_0001, orf6.3176, CA1595" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 612598..615771 FT /gene="orf19.274" FT /Ca19Contig="Ca19-10046|85754..88927" FT /synonym="orf19.7906, IPF27095.1, IPF10122.3, Contig4- FT 2667_0008, Contig4-2667_0010, orf6.3175, orf6.4803, FT CA2774" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; FT transcriptionally activated by Mnl1p under weak acid FT stress" FT CDS 616026..616598 FT /gene="orf19.275" FT /Ca19Contig="Ca19-10046|89182..89754" FT /synonym="orf19.7907, IPF27052.1, IPF10123.1, Contig4- FT 2667_0007, orf6.4804, CA2775" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(616568..617980) FT /gene="orf19.276" FT /Ca19Contig="Ca19-10046|complement(89724..91136)" FT /synonym="orf19.7908, IPF27015.1, IPF10124.1, Contig4- FT 2667_0006, orf6.4805, CA2776" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; FT increased transcription is observed in an azole-resistant FT strain that overexpresses MDR1" FT CDS 618663..620207 FT /gene="orf19.277" FT /Ca19Contig="Ca19-10046|91819..93363" FT /synonym="orf19.7909, IPF27007.1, IPF10126.2, Contig4- FT 2667_0004, orf6.4806, CA2777" FT /remarks="Putative thiamin-phosphate pyrophosphorylase, FT hydroxyethylthiazole kinase; fungal-specific (no human or FT murine homolog)" FT CDS complement(620244..621671) FT /gene="orf19.278" FT /Ca19Contig="Ca19-10046|complement(93400..94827)" FT /synonym="orf19.7910, IPF27013.1, IPF10127.2, Contig4- FT 2667_0002, orf6.4807, CA2778" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 622329..622739 FT /gene="orf19.279" FT /Ca19Contig="Ca19-10046|95485..95895" FT /synonym="orf19.7911, IPF27060.1, IPF19768.1, orf6.4808, FT CA2779" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(622840..623250) FT /gene="orf19.280" FT /Ca19Contig="Ca19-10046|complement(95996..96406)" FT /synonym="orf19.7912, IPF19669.1, Contig4-3050_0012, FT orf6.4297, orf6.4809" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; FT possibly spurious ORF (Annotation Working Group FT prediction)" FT CDS complement(846871..847842) FT /gene="orf19.2803" FT /Ca19Contig="Ca19-10160|3763..4734" FT /synonym="orf19.10321, orf6.1494, IPF24536.1, IPF11525.2, FT Contig4-2893_0015, CA0517" FT /remarks="Homolog of S. cerevisiae coproporphyrinogen III FT oxidase; antigenic in human, mouse; localizes to cell FT surface of yeast-form, not hyphae; soluble in hyphae; iron- FT regulated expression; macrophage-downregulated protein; FT not Rfg1p regulated" FT CDS join(845061..845231,845325..846020) FT /gene="orf19.2804" FT /Ca19Contig="Ca19-10160|complement(5585..6118)" FT /synonym="orf19.10322, IPF24538.1, IPF11526.2, Contig4- FT 2893_0012, orf6.1493, orf6.4589, CA0516" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS join(complement(843213..844235), FT complement(841752..843209)) FT /gene="orf19.2805" FT /Ca19Contig="Ca19-10160|join(7370..8392,8396..9853)" FT /synonym="orf19.10323, orf19.10324, IPF19631.1, FT IPF24534.1, IPF19632.2, IPF11531.2, Contig4-2893_0007, FT Contig4-2893_0010, orf6.1492, orf6.4587, orf6.4588, FT CA2623, CA2622, orf19.2806" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; FT expression regulated during planktonic growth" FT CDS complement(836842..840078) FT /gene="orf19.2808" FT /Ca19Contig="Ca19-10160|11527..14763" FT /synonym="orf19.10326, IPF24542.1, IPF9499.2, Contig4- FT 2893_0005, Contig4-2893_0006, orf6.4585, CA2621" FT /remarks="Predicted zinc-finger protein of unknown FT function, not essential for viability" FT CDS complement(833071..835749) FT /gene="orf19.2809" FT /Ca19Contig="Ca19-10160|15856..18534" FT /synonym="orf19.10327, IPF24526.1, IPF9496.1, Contig4- FT 2893_0003, orf6.4584, CA2620" FT /remarks="Predicted peroxisomal carnitine acetyl FT transferase; Ura+ deletion strain has no obvious FT metabolic, hyphal, or virulence defects; transcription FT induced by macrophage engulfment, hyphal growth, FT starvation, or nonfermentable carbon sources" FT CDS 623509..624606 FT /gene="orf19.281" FT /Ca19Contig="Ca19-10046|96665..97762" FT /synonym="orf19.7913, IPF27023.1, IPF3798.2, orf6.4810, FT CA2780" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(829240..831153) FT /gene="orf19.2810" FT /Ca19Contig="Ca19-10160|20419..22365" FT /synonym="orf19.10328, IPF24528.1, IPF9490.2, Contig4- FT 1993_0003, orf6.4583, CA2619" FT /remarks="Putative amino acid permease; fungal-specific FT (no human or murine homolog)" FT CDS complement(827105..828667) FT /gene="orf19.2812" FT /Ca19Contig="Ca19-10160|22938..24449" FT /synonym="orf19.10330, IPF24531.1, IPF19762.1, Contig4- FT 1935_0004, orf6.4581, CA2618" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(822760..822888) FT /gene="orf19.2813" FT /Ca19Contig="Ca19-10160|28666..29805" FT /synonym="orf19.10331, IPF24535.1, IPF3539.2, Contig4- FT 3051_0001, orf6.4580, CA2617" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 624748..625404 FT /gene="orf19.284" FT /Ca19Contig="Ca19-10046|97904..98560" FT /synonym="orf19.7916, IPF27036.1, IPF3805.2, orf6.4813, FT CA2781" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 625654..626043 FT /gene="orf19.285" FT /Ca19Contig="Ca19-10046|98810..99199" FT /synonym="orf19.7917, IPF27074.1, IPF3806.1, Contig4- FT 3050_0029, orf6.4814, CA2782" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 626521..627054 FT /gene="orf19.286" FT /Ca19Contig="Ca19-10046|99677..100210" FT /synonym="orf19.7918, IPF27054.1, IPF3808.1, IPF3808, FT Contig4-3050_0026, orf6.4815, CA2783" FT /remarks="Decreased transcription is observed upon FT fluphenazine treatment; possibly spurious ORF (Annotation FT Working Group prediction)" FT CDS complement(627085..627669) FT /gene="orf19.287" FT /Ca19Contig="Ca19-10046|complement(100241..100825)" FT /synonym="orf19.7919, IPF27050.1, IPF3810.1, Contig4- FT 3050_0025, orf6.4816, CA2784" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; FT repressed by nitric oxide; identified in detergent- FT resistant membrane fraction (possible lipid raft FT component)" FT CDS complement(628645..630489) FT /gene="orf19.288" FT /Ca19Contig="Ca19-10046|complement(101801..103645)" FT /synonym="orf19.7920, IPF26987.1, IPF3814.2, Contig4- FT 3050_0022, orf6.4817, CA2785" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(630976..635319) FT /gene="orf19.290" FT /Ca19Contig="Ca19-10046|complement(104132..108475)" FT /synonym="orf19.7922, IPF27067.1, IPF3818.3, Contig4- FT 3050_0020, orf6.4303, orf6.4819, CA2786" FT /remarks="Predicted UDP-glucose:glycoprotein FT glucosyltransferase; required for wild-type 1,6-beta-D- FT glucan biosynthesis, hyphal growth, and virulence in mouse FT IV infection; production in S. cerevisiae partially FT complements defects of a kre5 mutant" FT CDS complement(635504..636424) FT /gene="orf19.291" FT /Ca19Contig="Ca19-10046|complement(108660..109580)" FT /synonym="orf19.7923, IPF27029.1, IPF19948.1, Contig4- FT 3050_0016, Contig4-3050_0017, orf6.4302, CA2409" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(636700..637356) FT /gene="orf19.292" FT /Ca19Contig="Ca19-10046|complement(109856..110512)" FT /synonym="orf19.7924, IPF27038.1, IPF3821.1, orf6.4301" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(637498..638595) FT /gene="orf19.295" FT /Ca19Contig="Ca19-10046|complement(110654..111751)" FT /synonym="orf19.7927, IPF27021.1, IPF3831.1, Contig4- FT 3050_0013, orf6.4298" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 638852..639262 FT /gene="orf19.296" FT /Ca19Contig="Ca19-10046|112008..112418" FT /synonym="orf19.7928, IPF27058.1, IPF3833.1, CA2408" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS join(complement(639871..639935), FT complement(639363..639789)) FT /gene="orf19.297" FT /Ca19Contig="Ca19-10046|complement(112519..112929)" FT /synonym="orf19.7929, IPF27061.1, IPF3836.2, Contig4- FT 3050_0011, orf6.4296" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 639934..640437 FT /gene="orf19.298" FT /Ca19Contig="Ca19-10046|113090..113593" FT /synonym="IPF27056.1, IPF18470.1, orf6.4295" FT /remarks="ORF Predicted by Annotation Working Group" FT CDS complement(640172..641584) FT /gene="orf19.299" FT /Ca19Contig="Ca19-10046|complement(113328..114740)" FT /synonym="orf19.7931, IPF27014.1, IPF3838.2, Contig4- FT 3050_0009, orf6.4294, CA2407" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 642341..643924 FT /gene="orf19.300" FT /Ca19Contig="Ca19-10046|115497..117080" FT /synonym="orf19.7932, orf19.7933, IPF26999.1, IPF3840.1, FT Contig4-3050_0007, orf6.4293, CA2406" FT /remarks="Protein described as an actin interacting FT protein; regulated by Gcn4p; induced in response to amino FT acid starvation (3-aminotriazole treatment); repressed in FT the presence of elevated CO2" FT CDS complement(644594..646855) FT /gene="orf19.301" FT /Ca19Contig="Ca19-10046|complement(117750..120011)" FT /synonym="orf19.7933, IPF26975.1, IPF3844.2, Contig4- FT 3050_0006, orf6.4292, CA2405" FT /remarks="Putative GPI-anchored protein of unknown FT function; regulated by Nrg1p, Tup1p" FT CDS 652135..652617 FT /gene="orf19.302" FT /Ca19Contig="Ca19-10046|125291..125773" FT /synonym="orf19.7934, IPF27043.1, IPF1468.1, Contig4- FT 2823_0003, orf6.4440, CA2508" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 653335..654852 FT /gene="orf19.304" FT /Ca19Contig="Ca19-10046|126491..128008" FT /synonym="orf19.7936, IPF26998.1, IPF1471.2, Contig4- FT 2823_0004, orf6.4442, CA2509" FT /remarks="Putative transporter similar to MDR proteins; FT fungal-specific (no human or murine homolog)" FT CDS 655067..656317 FT /gene="orf19.305" FT /Ca19Contig="Ca19-10046|128223..129473" FT /synonym="orf19.7937, IPF27019.1, IPF1472.2, Contig4- FT 2823_0007, orf6.4443, CA2510" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; FT greater mRNA abundance observed in a cyr1 homozygous null FT mutant than in wild type" FT CDS 656646..658505 FT /gene="orf19.306" FT /Ca19Contig="Ca19-10046|129802..131661" FT /synonym="orf19.7938, IPF26986.1, IPF1474.2, Contig4- FT 2823_0010, orf6.4444, CA2511, ABPD" FT /remarks="Protein of unknown function; transcription is FT induced upon filamentous growth and in response to alpha FT pheromone in SpiderM medium" FT CDS complement(658558..660030) FT /gene="orf19.307" FT /Ca19Contig="Ca19-10046|complement(131714..133186)" FT /synonym="orf19.7939, IPF27011.1, IPF1476.1, Contig4- FT 2823_0011, orf6.4445, CA2512" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS join(155109..157214,157216..157794) FT /gene="orf19.3071" FT /Ca19Contig="Ca19-1948|7750..10434" FT /synonym="IPF19027.1, IPF9605.2, Contig4-2784_0008, FT Contig4-2784_0009, orf6.1170, orf6.1592, CA0578, FT orf19.1812" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 661428..662963 FT /gene="orf19.308" FT /Ca19Contig="Ca19-10046|134584..136119" FT /synonym="orf19.7940, IPF27003.1, IPF1478.1, orf6.4446, FT CA2513" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(663763..665340) FT /gene="orf19.309" FT /Ca19Contig="Ca19-10046|complement(136919..138496)" FT /synonym="orf19.7941, IPF27000.1, IPF1479.1, Contig4- FT 1938_0003, orf6.4447, CA6173" FT /remarks="Putative allantoate permease; nitrogen FT catabolite repressed gene, induced in absence of preferred FT N sources; gene regulation by nitrogen source requires FT Gat1p; fungal-specific (no human or murine homolog)" FT CDS join(complement(666719..667735), FT complement(666215..666715)) FT /gene="orf19.310" FT /Ca19Contig="Ca19-10046|complement(join(139875..140891,1393 FT 71..139871))" FT /synonym="orf19.7943, IPF1480.1, IPF1481.1, Contig4- FT 1938_0004, Contig4-1938_0005, orf6.4448, orf6.4450, FT CA6248, orf19.312" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(668065..669777) FT /gene="orf19.313" FT /Ca19Contig="Ca19-10046|complement(141221..142933)" FT /synonym="orf19.7944, IPF27017.1, IPF1484.2, Contig4- FT 2361_0006, orf6.4451, orf6.5645, CA2514" FT /remarks="Putative allantoin permease; fungal-specific (no FT human or murine homolog)" FT CDS 671267..674266 FT /gene="orf19.314" FT /Ca19Contig="Ca19-10046|144423..147422" FT /synonym="orf19.7946, IPF6747.2, IPF29919.1, Contig4- FT 2797_0025, orf6.5644, CA3394" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(674259..674873) FT /gene="orf19.315" FT /Ca19Contig="Ca19-10046|complement(147415..148029)" FT /synonym="orf19.7947, IPF27041.1, IPF6748.2, Contig4- FT 2797_0022, orf6.5643, CA3393" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; FT possibly spurious ORF (Annotation Working Group FT prediction)" FT CDS 236827..239037 FT /gene="orf19.3153" FT /Ca19Contig="Ca19-10169|2186..3658" FT /synonym="orf19.10663, IPF24141.1, IPF15141.2, Contig4- FT 2116_0004, orf6.1660, CA0623" FT /remarks="Phosphatidylinositol-4-phosphate 5-kinase; FT activity induced by phosphatidic acid (Pld1p product); FT associated with hyphal growth under some, not all, FT conditions; functional homolog of S. cerevisiae Mss4p; FT macrophage/pseudohyphal-repressed" FT CDS 239609..241063 FT /gene="orf19.3154" FT /Ca19Contig="Ca19-10169|4230..5684" FT /synonym="orf19.10664, IPF312.3, IPF15139.2, Contig4- FT 2595_0002, orf6.1661, orf6.2694, CA0624" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(241287..244550) FT /gene="orf19.3156" FT /Ca19Contig="Ca19-10169|complement(5908..9171)" FT /synonym="orf19.10665, IPF13504.2, IPF310.3, Contig4- FT 2595_0003, Contig4-2595_0004, Contig4-2595_0005, FT orf6.1663, orf6.2693, CA1270" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; FT transcriptionally activated by Mnl1p under weak acid FT stress" FT CDS complement(248564..249991) FT /gene="orf19.3158" FT /Ca19Contig="Ca19-10169|complement(13185..14612)" FT /synonym="orf19.10667, IPF19726.1, IPF13496.3, Contig4- FT 1635_0002, orf6.2691, orf6.641, CA1269" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS join(250364..252118,252120..255518,255522..255947, FT 255946..257931) FT /gene="orf19.3159" FT /Ca19Contig="Ca19-10169|14985..18578" FT /synonym="orf19.9300, orf19.9301, orf19.10668, IPF25622.1, FT IPF25609.1, IPF18641.1, IPF18640.1, IPF24144.1, FT IPF14693.2, orf6.3233, orf6.3232, orf6.2690, YBL004, FT CA1640, CA1639, CA1268, orf19.1732, orf19.1733" FT /remarks="Protein likely to be essential for growth, based FT on an insertional mutagenesis strategy; similar to S. FT cerevisiae Utp20p, which is a putative snoRNA-binding FT protein; downregulated in core stress response" FT CDS 675138..676034 FT /gene="orf19.316" FT /Ca19Contig="Ca19-10046|148078..149190" FT /synonym="orf19.7948, IPF27025.1, IPF6749.2, Contig4- FT 2797_0021, orf6.5642, CA3392" FT /remarks="Protein described as protein transport factor; FT antigenic during murine systemic infection; macrophage- FT downregulated protein abundance" FT CDS complement(676162..677085) FT /gene="orf19.317" FT /Ca19Contig="Ca19-10046|complement(149318..150241)" FT /synonym="orf19.7949, IPF6750.1, IPF19266.2, Contig4- FT 2797_0017, orf6.462, orf6.5641, CA3391" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(677491..678900) FT /gene="orf19.318" FT /Ca19Contig="Ca19-10046|complement(150647..152056)" FT /synonym="orf19.7950, IPF6752.1, IPF19265.1, Contig4- FT 2797_0013, orf6.463, orf6.5640" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(679306..679542) FT /gene="orf19.319" FT /Ca19Contig="Ca19-10046|complement(152462..152812)" FT /synonym="orf19.7951, IPF6754.1, IPF19264.2, Contig4- FT 2797_0011, orf6.464, orf6.5639, CA3389" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 680583..681584 FT /gene="orf19.320" FT /Ca19Contig="Ca19-10046|153739..154740" FT /synonym="orf19.7952, IPF27026.1, IPF6755.1, Contig4- FT 2797_0005, orf6.5638, CA3388" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(681961..683610) FT /gene="orf19.321" FT /Ca19Contig="Ca19-10046|complement(155117..156943)" FT /synonym="orf19.7953, IPF6757.1, IPF29879.1, Contig4- FT 2797_0003, Contig4-2797_0004, orf6.5637, CA3387" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(685055..685489) FT /gene="orf19.322" FT /Ca19Contig="Ca19-10046|complement(158211..158645)" FT /synonym="orf19.7954, IPF6758.2, IPF29887.1, orf6.5636, FT CA3386" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 685658..690097 FT /gene="orf19.323" FT /Ca19Contig="Ca19-10046|158814..163253" FT /synonym="orf19.7955, IPF6764.2, IPF29893.1, Contig4- FT 2777_0010, orf6.5635, CA3385" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 690503..693298 FT /gene="orf19.325" FT /Ca19Contig="Ca19-10046|163659..166454" FT /synonym="orf19.7957, IPF26957.1, IPF8362.2, orf6.5633, FT CA3384" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 693605..694060 FT /gene="orf19.326" FT /Ca19Contig="Ca19-10046|166761..167216" FT /synonym="orf19.7958, IPF27062.1, IPF8359.2, Contig4- FT 2705_0001, orf6.5632, CA3383" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(694348..694749) FT /gene="orf19.327" FT /Ca19Contig="Ca19-10046|complement(167504..167905)" FT /synonym="orf19.7959, IPF27053.1, IPF8358.1, Contig4- FT 2705_0004, orf6.5631, CA3382" FT /remarks="Protein described as histone H2A; amphotericin B FT repressed; flucytosine induced; RNA abundance regulated by FT tyrosol and cell density" FT CDS complement(695002..696984) FT /gene="orf19.328" FT /Ca19Contig="Ca19-10046|complement(168158..170140)" FT /synonym="orf19.7960, IPF26980.1, IPF8357.2, Contig4- FT 2705_0009, orf6.5630, CA3381" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; FT induced during infection of murine kidney, compared to FT growth in vitro; has murine homolog" FT CDS complement(697459..698826) FT /gene="orf19.329" FT /Ca19Contig="Ca19-10046|complement(170615..171982)" FT /synonym="orf19.7961, IPF27016.1, IPF8351.2, Contig4- FT 2705_0010, Contig4-2705_0011, orf6.5629, CA3380" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 699879..700112 FT /gene="orf19.330.1" FT /Ca19Contig="Ca19-10046|173035..173268" FT /synonym="IPF26964.1, IPF8348.1, CA3378" FT /remarks="ORF Predicted by Annotation Working Group" FT CDS complement(699012..699677) FT /gene="orf19.331" FT /Ca19Contig="Ca19-10046|complement(172168..172842)" FT /synonym="orf19.7963, IPF27042.1, IPF8350.1, Contig4- FT 2705_0012, orf6.5627, CA3379" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(700179..702284) FT /gene="orf19.332" FT /Ca19Contig="Ca19-10046|complement(173335..175440)" FT /synonym="orf19.7964, IPF8347.2, IPF19023.2, Contig4- FT 2705_0015, orf6.1189, orf6.5626, CA3377" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 704699..706279 FT /gene="orf19.333" FT /Ca19Contig="Ca19-10046|177855..179435" FT /synonym="orf19.7965, IPF8342.3, IPF12764.2, Contig4- FT 2216_0002, Contig4-2705_0018, orf6.1188, orf6.1275, FT orf6.5625, CA0357" FT /remarks="Putative purine-cytosine permease of pyrimidine FT salvage; similar to S. cerevisiae Fcy2p; mutation FT associated with resistance to flucytosine in clinical FT isolates; transposon mutation affects filamentation; FT farnesol-upregulated in biofilm" FT CDS complement(709045..709617) FT /gene="orf19.334" FT /Ca19Contig="Ca19-10046|complement(182201..182773)" FT /synonym="orf19.7966, IPF12758.2, IPF29886.1, Contig4- FT 2216_0007, orf6.1276, orf6.7218, CA0394" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 714765..717206 FT /gene="orf19.335" FT /Ca19Contig="Ca19-10046|187921..190362" FT /synonym="orf19.7967, IPF26972.1, IPF13709.2, orf6.7219, FT CA4629" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(717366..717875) FT /gene="orf19.336" FT /Ca19Contig="Ca19-10046|complement(190522..191133)" FT /synonym="orf19.7969, orf6.7220, IPF27048.1, IPF1537.1, FT Contig4-3090_0001, CA4630" FT /remarks="Similar to oxidoreductases; transcriptionally FT regulated by iron; expression greater in high iron" FT CDS join(complement(718930..719023), FT complement(718247..718806)) FT /gene="orf19.337" FT /Ca19Contig="Ca19-10046|complement(191403..192068)" FT /synonym="orf19.7970, IPF27044.1, IPF1535.1, Contig4- FT 3090_0002, orf6.7221, CA4631" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(719337..722480) FT /gene="orf19.338" FT /Ca19Contig="Ca19-10046|complement(192493..195636)" FT /synonym="orf19.7971, IPF27096.1, IPF1531.2, Contig4- FT 3090_0006, Contig4-3090_0007, orf6.7222, CA4632" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; Hog1p- FT downregulated; shows colony morphology-related gene FT regulation by Ssn6p" FT CDS complement(723414..725138) FT /gene="orf19.339" FT /Ca19Contig="Ca19-10046|complement(196570..198294)" FT /synonym="orf19.7972, IPF26993.1, IPF1529.1, Contig4- FT 3090_0011, orf6.7223, CA4633" FT /remarks="Putative NADH dehydrogenase that could act FT alternatively to complex I in respiration; caspofungin FT repressed; fungal-specific (no human or murine homolog)" FT CDS complement(726137..726736) FT /gene="orf19.340" FT /Ca19Contig="Ca19-10046|complement(199293..199892)" FT /synonym="orf19.7973, IPF27045.1, IPF1526.1, Contig4- FT 3090_0013, orf6.7224, CA4634" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(726939..728870) FT /gene="orf19.341" FT /Ca19Contig="Ca19-10046|complement(200095..202026)" FT /synonym="orf19.7974, IPF26983.1, IPF1524.2, Contig4- FT 3090_0015, orf6.7225, CA4635" FT /remarks="Putative spermidine export pump; fungal-specific FT (no human or murine homolog)" FT CDS complement(729454..731409) FT /gene="orf19.342" FT /Ca19Contig="Ca19-10046|complement(202610..204565)" FT /synonym="orf19.7975, IPF26981.1, IPF1520.1, Contig4- FT 3090_0018, orf6.7226, CA4636" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; FT decreased transcription is observed in an azole-resistant FT strain that overexpresses CDR1 and CDR2; possibly spurious FT ORF (Annotation Working Group prediction)" FT CDS complement(734077..734892) FT /gene="orf19.344" FT /Ca19Contig="Ca19-10046|complement(207233..208048)" FT /synonym="orf19.7977, IPF27032.1, IPF1514.2, Contig4- FT 3090_0023, orf6.7228, CA4637" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; FT increased transcription is observed upon fluphenazine FT treatment or in an azole-resistant strain that FT overexpresses CDR1 and CDR2; possibly transcriptionally FT regulated by Tac1p; possibly spurious ORF (Annotation FT Working Group prediction)" FT CDS 738046..739521 FT /gene="orf19.345" FT /Ca19Contig="Ca19-10046|211202..212677" FT /synonym="orf19.7978, IPF27012.1, IPF1510.1, Contig4- FT 3090_0030, orf6.7229, CA4638" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(739659..741221) FT /gene="orf19.346" FT /Ca19Contig="Ca19-10046|complement(212815..214377)" FT /synonym="orf19.7979, IPF27006.1, IPF1509.2, Contig4- FT 3090_0031, orf6.7230, CA4639" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 743811..744653 FT /gene="orf19.347" FT /Ca19Contig="Ca19-10046|216967..217809" FT /synonym="orf19.7980, IPF27030.1, IPF1506.1, Contig4- FT 3090_0035, orf6.7231, CA4640" FT /remarks="Protein induced during the mating process" FT CDS 746404..748560 FT /gene="orf19.348" FT /Ca19Contig="Ca19-10046|219560..221716" FT /synonym="orf19.7981, IPF26976.1, IPF1505.2, Contig4- FT 3090_0037, orf6.7232, CA4641" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(748955..751060) FT /gene="orf19.349" FT /Ca19Contig="Ca19-10046|complement(222111..224216)" FT /synonym="orf19.7982, IPF26978.1, IPF1500.2, Contig4- FT 3090_0039, orf6.7233, CA4642" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(751383..752138) FT /gene="orf19.350" FT /Ca19Contig="Ca19-10046|complement(224539..225294)" FT /synonym="orf19.7983, IPF27035.1, IPF1499.1, Contig4- FT 3090_0040, orf6.7234, Y13, CA4643" FT /remarks="Alpha3 (C9) subunit of the 20S proteasome; FT transcription is regulated by Mig1p" FT CDS 752588..753055 FT /gene="orf19.351" FT /Ca19Contig="Ca19-10046|225744..226211" FT /synonym="orf19.7984, IPF27055.1, IPF1497.1, Contig4- FT 3090_0042, orf6.7235, CA4644" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 753301..754932 FT /gene="orf19.352" FT /Ca19Contig="Ca19-10046|226457..228088" FT /synonym="orf19.7985, IPF26995.1, IPF1496.1, Contig4- FT 3090_0045, orf6.7236, CA4645" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(754976..756031) FT /gene="orf19.353" FT /Ca19Contig="Ca19-10046|complement(228132..229187)" FT /synonym="orf19.7986, IPF27024.1, IPF1495.1, Contig4- FT 3090_0046, orf6.7237, CA4646" FT /remarks="Putative SUMO deconjugation enzyme that cleaves FT the small ubiquitin-like modifier (SUMO) off proteins" FT CDS 756377..757849 FT /gene="orf19.354" FT /Ca19Contig="Ca19-10046|229533..231005" FT /synonym="orf19.7987, IPF27010.1, IPF1493.1, Contig4- FT 3090_0048, orf6.7238, CA4647" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(758016..759287) FT /gene="orf19.355" FT /Ca19Contig="Ca19-10046|complement(231172..232443)" FT /synonym="orf19.7988, IPF27018.1, IPF1492.1, Contig4- FT 3090_0049, orf6.7239" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS join(complement(760690..760730), FT complement(759830..760580)) FT /gene="orf19.356" FT /Ca19Contig="Ca19-10046|complement(232986..233408)" FT /synonym="orf19.7989, IPF27039.1, IPF1491.1, Contig4- FT 3090_0050, orf6.7240" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; FT opaque-specific transcription; transcription is repressed FT in response to alpha pheromone in SpiderM medium" FT CDS 762050..762901 FT /gene="orf19.357" FT /Ca19Contig="Ca19-10046|235092..236057" FT /synonym="orf19.7990, IPF27027.1, IPF1487.2, Contig4- FT 2361_0002, orf6.7241" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS join(complement(763768..763796),complement(763621..763690), FT complement(762969..763619)) FT /gene="orf19.359" FT /Ca19Contig="Ca19-10046|complement(join(236923..236951,2361 FT 25..236845))" FT /synonym="orf19.7992, IPF27034.1, IPF1485.1, Contig4- FT 2361_0003, orf6.7243" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 764340..766052 FT /gene="orf19.360" FT /Ca19Contig="Ca19-10046|237495..238337" FT /synonym="orf19.7993, IPF27031.1, IPF18195.1, orf6.7244" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 148267..150702 FT /gene="orf19.5376" FT /Ca19Contig="Ca19-10227|complement(2843..5278)" FT /synonym="orf19.12831, IPF16051.2, IPF21697.1, IPF28022.1, FT Contig4-2974_0004, orf6.1589, orf6.4138, CA0577, FT orf19.3068" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS join(146267..147220,147222..147632) FT /gene="orf19.5377" FT /Ca19Contig="Ca19-10227|complement(5908..7272)" FT /synonym="orf19.12832, IPF16053.3, IPF21733.1, IPF8228.2, FT Contig4-2974_0006, orf6.1588, orf6.4139, CA2295, FT orf19.3067" FT /remarks="Histone deacetylase; similar to S. cerevisiae FT Hos2p; has conserved deacetylation motif; slightly greater FT expression in white cells than in opaque cells" FT CDS complement(145183..145926) FT /gene="orf19.5378" FT /Ca19Contig="Ca19-10227|7613..8356" FT /synonym="orf19.12833, IPF21751.1, IPF8226.2, Contig4- FT 2974_0008, orf6.4140, CA2296" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 143573..144982 FT /gene="orf19.5379" FT /Ca19Contig="Ca19-10227|complement(8557..9966)" FT /synonym="orf19.12834, IPF21722.1, IPF8225.1, Contig4- FT 2974_0009, orf6.4141, CA2297" FT /remarks="Protein described as similar to sterol C-24 FT reductase; fluconazole-induced; caspofungin repressed" FT CDS 140435..143020 FT /gene="orf19.5380" FT /Ca19Contig="Ca19-10227|complement(10519..13104)" FT /synonym="orf19.12835, IPF21694.1, IPF8224.2, Contig4- FT 2974_0012, orf6.4142, CA2298" FT /remarks="Putative transcription factor with zinc cluster FT DNA-binding motif; has similarity to S. cerevisiae Lys14p, FT which is a transcription factor involved in the regulation FT of lysine biosynthesis genes" FT CDS 137633..139984 FT /gene="orf19.5381" FT /Ca19Contig="Ca19-10227|complement(13555..15906)" FT /synonym="orf19.12836, IPF19392.2, IPF8222.2, Contig4- FT 2974_0014, orf6.206, orf6.4143, CA2299" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 138357..138818 FT /gene="orf19.5382" FT /Ca19Contig="Ca19-10227|complement(14721..15182)" FT /synonym="IPF8221.1, IPF18491.1, orf6.205, orf6.4144" FT /remarks="ORF Predicted by Annotation Working Group" FT CDS 133121..135808 FT /gene="orf19.5383" FT /Ca19Contig="Ca19-10227|complement(17731..20418)" FT /synonym="orf19.12838, IPF21692.1, IPF8215.2, Contig4- FT 2974_0020, orf6.4145, CA2300" FT /remarks="Plasma membrane H(+)-ATPase; highly expressed, FT comprising 20-40% of total plasma membrane protein; FT abundance increases at stationary phase transition; FT fluconazole induced; caspofungin repressed; upregulated in FT RHE model" FT CDS 123508..126825 FT /gene="orf19.5384" FT /Ca19Contig="Ca19-10227|complement(26714..30031)" FT /synonym="orf19.12839, IPF21803.1, IPF11660.2, orf6.8620, FT CA5750" FT /remarks="Chitin synthase required for synthesis of long- FT chitin fibrils; nonessential; 8 or 9 membrane spanning FT regions; mRNA present in yeast and hyphae; induced during FT cell wall regeneration; fungal-specific (no human or FT murine homologs)" FT CDS 118538..122578 FT /gene="orf19.5387" FT /Ca19Contig="Ca19-10227|complement(30961..35001)" FT /synonym="orf19.12842, IPF21788.1, IPF11663.2, Contig4- FT 2666_0003, Contig4-2666_0004, orf6.8623, CA5751" FT /remarks="Protein described as a vacuolar sorting protein; FT downregulated upon adherence to polystyrene" FT CDS complement(116949..118292) FT /gene="orf19.5388" FT /Ca19Contig="Ca19-10227|35247..36590" FT /synonym="orf19.12843, IPF21735.1, IPF1055.2, Contig4- FT 2666_0002, orf6.8624, CA5752" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS join(complement(113737..115300), FT complement(113161..113660)) FT /gene="orf19.5389" FT /Ca19Contig="Ca19-10227|38239..39819" FT /synonym="orf19.12844, orf6.8625, IPF21713.1, IPF1059.2, FT Contig4-3071_0032, CA5753" FT /remarks="Forkhead transcription factor; morphogenesis FT regulator; required for wild-type hyphal transcription, FT cell separation, and for virulence in cell culture; mutant FT lacks true hyphae, is constitutively pseudohyphal; FT upregulated in RHE model" FT CDS complement(113161..113604) FT /gene="orf19.5390" FT /Ca19Contig="Ca19-10227|39935..40378" FT /synonym="orf19.12845, IPF21770.1, IPF1060.2, Contig4- FT 3071_0030, orf6.8626" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; FT possibly spurious ORF (Annotation Working Group FT prediction)" FT CDS 109086..112745 FT /gene="orf19.5391" FT /Ca19Contig="Ca19-10227|complement(40794..44453)" FT /synonym="orf19.12846, IPF21794.1, IPF1063.2, Contig4- FT 3071_0027, Contig4-3071_0028, orf6.8627, CA5755" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 107369..108898 FT /gene="orf19.5392" FT /Ca19Contig="Ca19-10227|complement(44641..46170)" FT /synonym="orf19.12847, IPF21718.1, IPF1065.1, Contig4- FT 3071_0022, orf6.8628, CA5756" FT /remarks="N-acetylglucosamine (GlcNAc)-specific FT transporter; role in GlcNAc (but not serum) induced hyphal FT growth; localizes to plasma membrane; induced by GlcNAc, FT macrophage engulfment; 12 transmembrane, major facilitator FT superfamily" FT CDS 103831..105315 FT /gene="orf19.5393" FT /Ca19Contig="Ca19-10227|complement(48224..49708)" FT /synonym="orf19.12848, IPF21727.1, IPF1067.1, Contig4- FT 3071_0021, orf6.8629, CA5757" FT /remarks="Putative cysteine sulfinate decarboxylase; FT transcription is positively regulated by Tbf1p" FT CDS join(complement(98878..98888),complement(98473..98815)) FT /gene="orf19.5394.1" FT /Ca19Contig="Ca19-10227|join(54651..54661,54724..55066)" FT /synonym="IPF21796.1, IPF1071.1, Contig4-3071_0018, FT CA5759" FT /remarks="ORF Predicted by Annotation Working Group" FT CDS 99338..103045 FT /gene="orf19.5395" FT /Ca19Contig="Ca19-10227|complement(50494..54201)" FT /synonym="orf19.12850, IPF21795.1, IPF1069.1, Contig4- FT 3071_0019, orf6.8631, CA5758" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 97647..98375 FT /gene="orf19.5397" FT /Ca19Contig="Ca19-10227|complement(55164..55892)" FT /synonym="orf19.12852, IPF21753.1, IPF1072.1, Contig4- FT 3071_0017, orf6.8633, CA5760" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; FT decreased transcription is observed upon fluphenazine FT treatment" FT CDS 95652..97187 FT /gene="orf19.5399" FT /Ca19Contig="Ca19-10227|complement(56352..57887)" FT /synonym="orf19.12854, IPF21721.1, IPF1076.1, IPF21769.1, FT IPF1075.1, Contig4-3071_0014, orf6.8635, orf6.8636, FT CA5761, orf19.5400" FT /remarks="Secreted protein required for normal cell wall FT structure and for virulence; member of the IFF family" FT CDS 90578..92647 FT /gene="orf19.5401" FT /Ca19Contig="Ca19-10227|complement(60892..62961)" FT /synonym="orf19.12856, IPF21702.1, IPF1084.2, IPF1084.3, FT Contig4-3071_0012, orf6.8637, CA5762" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; FT decreased transcription is observed upon fluphenazine FT treatment" FT CDS 90951..91517 FT /gene="orf19.5402" FT /Ca19Contig="Ca19-10227|complement(62022..62588)" FT /synonym="IPF21765.1, IPF1081.2, orf6.8638" FT /remarks="ORF Predicted by Annotation Working Group" FT CDS 88912..90603 FT /gene="orf19.5404" FT /Ca19Contig="Ca19-10227|complement(62936..64627)" FT /synonym="orf19.12859, IPF21711.1, IPF1089.1, Contig4- FT 3071_0011, orf6.8640, CA5763" FT /remarks="Protein repressed during the mating process" FT CDS complement(83705..85030) FT /gene="orf19.5406" FT /Ca19Contig="Ca19-10227|68509..69834" FT /synonym="orf19.12861, IPF21737.1, IPF20031.1, Contig4- FT 3071_0005, Contig4-3071_0006, orf6.8642, CA5764" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(81718..83028) FT /gene="orf19.5407" FT /Ca19Contig="Ca19-10227|70511..71821" FT /synonym="orf19.12862, IPF21734.1, IPF1095.1, Contig4- FT 3071_0003, orf6.8643, CA5765" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(78180..80270) FT /gene="orf19.5408" FT /Ca19Contig="Ca19-10227|73269..75359" FT /synonym="orf19.12863, IPF21701.1, IPF1097.1, Contig4- FT 2289_0005, orf6.8644, CA5766" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(77128..77889) FT /gene="orf19.5409" FT /Ca19Contig="Ca19-10227|75650..76411" FT /synonym="orf19.12864, IPF21748.1, IPF1098.1, Contig4- FT 2289_0004, orf6.8645, CA5767" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(74962..76422) FT /gene="orf19.5410" FT /Ca19Contig="Ca19-10227|77117..78577" FT /synonym="orf19.12865, IPF21729.1, IPF1099.1, Contig4- FT 2289_0002, orf6.8646, CA5768" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 74279..74863 FT /gene="orf19.5411" FT /Ca19Contig="Ca19-10227|complement(78676..79260)" FT /synonym="orf19.12866, IPF21762.1, IPF1101.2, orf6.8647, FT CA5769" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 73019..74104 FT /gene="orf19.5412" FT /Ca19Contig="Ca19-10227|complement(79435..80520)" FT /synonym="orf19.12867, IPF21742.1, IPF1103.2, Contig4- FT 2864_0016, orf6.8648, CA5770" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(71714..72883) FT /gene="orf19.5413" FT /Ca19Contig="Ca19-10227|80656..81825" FT /synonym="orf19.12868, IPF21740.1, IPF1104.1, Contig4- FT 2864_0015, orf6.8649, CA5771" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 70068..71693 FT /gene="orf19.5416" FT /Ca19Contig="Ca19-10227|complement(81846..83471)" FT /synonym="orf19.12871, IPF21714.1, IPF1107.1, Contig4- FT 2864_0013, orf6.8652, CA5772" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(68046..68837) FT /gene="orf19.5417" FT /Ca19Contig="Ca19-10227|84702..85493" FT /synonym="orf19.12872, IPF21747.1, IPF1111.1, Contig4- FT 2864_0008, orf6.8653, CA5773" FT /remarks="Alkaline downregulated" FT CDS 66463..67896 FT /gene="orf19.5418" FT /Ca19Contig="Ca19-10227|complement(85643..87076)" FT /synonym="orf19.12873, IPF21724.1, IPF1113.1, Contig4- FT 2864_0007, orf6.8654, CA5774" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 65437..66054 FT /gene="orf19.5419" FT /Ca19Contig="Ca19-10227|complement(87485..88102)" FT /synonym="orf19.12874, IPF21757.1, IPF1114.1, Contig4- FT 2864_0006, orf6.8655, CA5775" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; FT caspofungin repressed" FT CDS complement(63988..65094) FT /gene="orf19.5420" FT /Ca19Contig="Ca19-10227|88445..89551" FT /synonym="orf19.12875, IPF21739.1, IPF1116.1, Contig4- FT 2864_0005, orf6.8656, CA5776" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 63282..63911 FT /gene="orf19.5422" FT /Ca19Contig="Ca19-10227|complement(89628..90257)" FT /synonym="orf19.12877, IPF21761.1, IPF1118.1, Contig4- FT 2864_0004, orf6.8658, CA5777" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; FT possibly spurious ORF (Annotation Working Group FT prediction)" FT CDS 62513..63145 FT /gene="orf19.5423" FT /Ca19Contig="Ca19-10227|complement(90394..91026)" FT /synonym="orf19.12878, orf6.8659, IPF21756.1, IPF1119.2, FT Contig4-2864_0003, CA5778" FT /remarks="Telomerase subunit; required for telomere FT maintenance in vivo; separable roles in telomerase FT activity and processivity; not required for catalytic FT activity in vitro; related to mammalian Tpp1p" FT CDS complement(59698..60243) FT /gene="orf19.5424" FT /Ca19Contig="Ca19-10227|93296..93841" FT /synonym="IPF21766.1, IPF1120.2, orf6.8660" FT /remarks="ORF Predicted by Annotation Working Group" FT CDS 59837..62410 FT /gene="orf19.5425" FT /Ca19Contig="Ca19-10227|complement(91129..93702)" FT /synonym="orf19.12880, IPF21691.1, IPF1121.2, Contig4- FT 2864_0001, Contig4-2864_0002, orf6.8661, CA5779" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(56493..59342) FT /gene="orf19.5426" FT /Ca19Contig="Ca19-10227|94197..97046" FT /synonym="orf19.12881, IPF21689.1, IPF1123.2, Contig4- FT 2896_0020, orf6.8662, CA5780" FT /remarks="Putative patatin-like phospholipase; macrophage- FT regulated gene; fungal-specific (no human or murine FT homolog)" FT CDS 55651..56463 FT /gene="orf19.5428" FT /Ca19Contig="Ca19-10227|complement(97076..97888)" FT /synonym="orf19.12883, IPF21746.1, IPF1126.2, Contig4- FT 2896_0018, orf6.8664, CA5781" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(53465..55492) FT /gene="orf19.5429" FT /Ca19Contig="Ca19-10227|98047..100074" FT /synonym="orf19.12884, IPF21704.1, IPF1127.2, Contig4- FT 2896_0014, Contig4-2896_0016, orf6.8665, CA5782" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS complement(52683..53342) FT /gene="orf19.5430" FT /Ca19Contig="Ca19-10227|100197..100856" FT /synonym="orf19.12885, IPF21749.1, IPF1128.1, Contig4- FT 2896_0013, orf6.8666, CA5783" FT /remarks="Predicted ORF in Assemblies 19, 20 and 21" FT CDS 51706..52413 FT /gene="orf19.5431" FT /Ca19Contig="Ca19-10227|complement(101126..101833)" FT /synonym="orf19.12886, IPF21750.1, IPF1129.1, Contig4- FT 2896_0012, or